Материалы

11.05.2023

Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis

Jun Liang1, Yingli Cai1 and Yiming Shao2*



*Correspondence:
Yiming Shao
zqyylj@163.com
1 Department of Emergency, the First People’s Hospital of Zhaoqing, Zhaoqing City, China
2 Jinan University, No.601, West Huangpu Avenue, Guangzhou 510632, China


27.01.2023

Perinatal presepsin assessment: a new sepsis diagnostic tool?

*Corresponding author: Prof. Diego Gazzolo, Neonatal Intensive Care Unit, G. D’Annunzio University, 65100 Chieti, Italy, Phone: +39 0871 358219, E-mail: dgazzolo@hotmail.com 

Valentina Botondi, Ebe D’Adamo, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante and Gabriella Levantini, Neonatal Intensive Care Unit, G. D’Annunzio University, Chieti, Italy

Mario Plebani, Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy. https://orcid.org/0000-0002-0270-1711

Oriana Trubiani, Department of Innovative Technologies in Medicine & Dentistry, University “G. D’Annunzio”, Chieti, Italy

Maria Chiara Strozzi, Antonio Maconi, Marta Betti and Annalisa Roveta, AO SS Antonio, Biagio and C. Arrigo Hospital, Alessandria, Italy. https://orcid.org/0000-0002-1904-7277 (A. Roveta) Francesca Gazzolo, Magna Graecia University, Catanzaro, Italy

27.01.2023

Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis

Iva Pospisilova1,2, Helena L. Brodska3, Marketa Bloomfield2,4, Klara Borecka1 and Jan Janota5,6,7*

1Department of Clinical Chemistry, First Faculty of Medicine, Thomayer University Hospital and Charles University, Prague, Czech Republic
2Department of Pediatrics, First Faculty of Medicine, Thomayer University Hospital and Charles University, Prague, Czech Republic
3The Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, General University Hospital and Charles University, Prague, Czech Republic
4Department of Immunology, Second Faculty of Medicine, Motol University Hospital and Charles University, Prague, Czech Republic
5Department of Obstetrics and Gynecology, Neonatal unit, Second Faculty of Medicine, Motol University Hospital and Charles University, Prague, Czech Republic
6Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
7Department of Neonatology, First Faculty of Medicine, Thomayer University Hospital and Charles University, Prague, Czech Republic

20.09.2022

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis

Dimitrios Velissaris , Nicholas Zareifopoulos , Vasileios Karamouzos , Evangelos Karanikolas , Charalampos Pierrakos , Ioanna Koniari , Menelaos Karanikolas 1. Department of Internal Medicine, General University Hospital of Patras, Patras, GRC 2.

Department of Psychiatry, General Hospital of Nikaia, Piraeus "Agios Panteleimon", Athens, GRC 3. Department of Internal Medicine, University of Patras School of Health Sciences, Patras, GRC 4. Intensive Care Unit, General University Hospital of Patras, Patras, GRC 5. Department of Internal Medicine, University of Patras, Patras, GRC 6. Intensive Care Unit, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, BEL 7. Department of Electrophysiology and Device, University Hospital of South Manchester NHS Foundation Trust, Manchester, GBR 8.

Department of Anesthesiology, Washington University School of Medicine, St. Louis, USA Corresponding author: Nicholas Zareifopoulos, nizareifopoulos@gmail.com
09.09.2022

Использование комбинации биомаркеров для ранней диагностики сепсиса у пациентов отделения реанимации и интенсивной терапии

М.Г. Вершинина 1, 2*, Н.И. Стериополо 1, А.М. Иванов 3, М.Е. Малышев 4

1 ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами
Президента РФ, Москва
2 ФГАУ «НМИЦ здоровья детей» Министерства здравоохранения РФ, Москва
3 ФГБВОУ ВО ВМедА им. С.М. Кирова, Санкт-Петербург
4 ГБУ СПб НИИ скорой помощи им. И.И. Джанелидзе, Санкт-Петербург
17.08.2022

Ранние лабораторные маркеры неонатального сепсиса — действительно ли они помогают врачу спасти жизнь?

А. Н. Обедин1, 2, А. Ю. Васильев2, Н. В. Зубенко2
1 Ставропольский государственный медицинский университет, Российская Федерация
2 Краевой клинический перинатальный центр No 1, Ставрополь, Российская Федерация

26.06.2022

Пресепсин как маркер сепсиса у онкологических больных после хирургических вмешательств

Н. К. Гуськова1, А. А. Морозова1, Д. А. Розенко1, А. В. Алешкина1, А. М. Скопинцев1, О. Н. Селютина1, Н. В. Голомеева1, Е. А. Гуськова2, А. К. Донская1, И. В. Целищева1, А. С. Ноздричева1

1. НМИЦ онкологии, г. Ростов-на-Дону, Российская Федерация
2. Клинико-диагностический центр «ДА ВИНЧИ», г. Ростов-на-Дону, Российская Федерация
Email: guskova.nailya@mail.ru

26.06.2022

Diagnostic Evaluation of Hematological Sepsis Score and Presepsin in Neonatal Sepsis

Marina Mamdouh Malky Ibrahim1, Dalia Ahmed El-Sewefy1, Mariam John Amin Ibrahim1, Shaimaa Abdelmalik Pessar1,*

1 Faculty of Medicine — Ain Shams University, Cairo, Egypt

*Corresponding Author: Dr Shaimaa Abdelmalik Pessar, Faculty of Medicine, Ain Shams University, Abbasseya, Cairo, Egypt.
Email: shaimaamalik@med.asu.edu.eg

15.06.2022

Diagnostic value of presepsin in odontogenic infection: a retrospective study

Eun‐Sung Kang and Jae‐Hoon Lee*

*Correspondence: lee201@dankook.ac.kr

Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, 119 Dandae‐ro, Cheonan, Chungcheongnam‐do 31116, Republic of Korea

03.06.2022

Пресепсин для диагностики раннего неонатального сепсиса: систематический обзор и мета-анализ

Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C.
Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 May 31. doi: 10.1001/jamapediatrics.2022.1647

01.06.2022

Presepsin: Hope in the Quest for the Holy Grail

Abhishek Samprathi1, Madhusudan Samprathi2, Mounika Reddy3

1 Department of Critical Care Medicine, Fortis Hospitals, Bengaluru, Karnataka, India
2,3 Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India

Corresponding Author: Madhusudan Samprathi, Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India, Phone: +917077703235, e-mail: madhu_1511@yahoo.com

30.05.2022

Современные маркеры воспалительного процесса в хирургической практике

А.М. Морозов, https://orcid.org/0000-0003-4213-5379, ammorozovv@gmail.com
А.Н. Сергеев, https://orcid.org/0000-0002-9657-8063
С.В. Жуков, https://orcid.org/0000-0002-3145-9776
Н.С. Новикова, https://orcid.org/0000-0003-4564-4777
М.А. Беляк, https://orcid.org/0000-0001-6125-7676
Тверской государственный медицинский университет; 170100, Россия, Тверь, ул. Советская, д. 4

14.05.2022

Perinatal presepsin assessment: a new sepsis diagnostic tool?

Valentina Botondi, Ebe D’Adamo, Mario Plebani, Oriana Trubiani, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante, Maria Chiara Strozzi, Antonio Maconi, Francesca Gazzolo, Marta Betti, Annalisa Roveta, Gabriella Levantini and Diego Gazzolo*

Valentina Botondi, Ebe D’Adamo, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante and Gabriella Levantini, Neonatal Intensive Care Unit, G. D’Annunzio University, Chieti, Italy

Mario Plebani, Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy. https://orcid.org/0000-0002-0270-1711

Oriana Trubiani, Department of Innovative Technologies in Medicine & Dentistry, University “G. D’Annunzio”, Chieti, Italy

Maria Chiara Strozzi, Antonio Maconi, Marta Betti and Annalisa Roveta, AO SS Antonio, Biagio and C. Arrigo Hospital, Alessandria, Italy. https://orcid.org/0000-0002-1904-7277 (A. Roveta)

Francesca Gazzolo, Magna Graecia University, Catanzaro, Italy

*Corresponding author: Prof. Diego Gazzolo, Neonatal Intensive Care Unit, G. D’Annunzio University, 65100 Chieti, Italy, Phone: +39 0871 358219, E-mail: dgazzolo@hotmail.com 

14.05.2022

Концентрация липополисахарид-связывающего белка и пресепсина у пациентов с вирусным поражением легких SARS-CoV-2, проживающих в Республике Крым

И.А. Яцков1, В.А. Белоглазов1, А.В. Кубышкин1, А.П.Николаева1, Е.Ю. Зяблицкая1, Ю.Е. Куницкая1, Э.Н. Лавренчук2

1 Медицинская академия имени С.И.Георгиевского Федерального государственного автономного образовательного учреждения высшего образования «Крымский федеральный университет имени В.И.Вернадского» Министерства науки и высшего образования Российской Федерации: 295007, Россия, Республика Крым, Симферополь, просп. Академика Вернадского, 4

2 Государственное бюджетное учреждение здравоохранения Республики Крым «Республиканская клиническая больница имени Н.А.Семашко»: 295017, Россия, Республика Крым, Симферополь, ул. Киевская, 69

25.04.2022

Пресепсин в диагностике нозокомиальной инфекции центральной нервной системы

С.А. Абудеев1, К.В. Киселев2, О.В. Паринов1, Ю.Д. Удалов1, М.В. Забелин1, А.С. Самойлов1, К.А. Попугаев1*

Отделение нейрореанимации и нейроанестезиологии

1 ФГБУ «ГНЦ — ФМБЦ имени А.И. Бурназяна» ФМБА,
Российская Федерация, 123098 Москва, ул. Маршала Новикова, д. 23
2 ГБОУ ВО «РНИМУ имени Н.И. Пирогова» Минздрава России, Российская Федерация, 117997 Москва, ул. Островитянова, д. 1

* Контактная информация: Попугаев Константин Александрович, доктор медицинских наук, заведующий отделением нейрореанимации ФГБУ ГНЦ ФМБЦ А.И. Бурназяна ФМБА России. E-mail: stan.popugaev@yahoo.com

11.04.2022

Biomarkers of Neonatal Sepsis: From Being Mere Numbers to Becoming Guiding Diagnostics

Sai Sravya Gude 1, Nikhil Chowdary Peddi 2, Sravya Vuppalapati 2, Shravya Venu Gopal 3, Harshita Marasandra Ramesh 4, Sai Sreeya Gude 5

1 Pediatrics, Guntur Medical College, Guntur, IND
2 Pediatrics, PES Institute of Medical Sciences and Research, Kuppam,IND
3 InternalMedicine,KasturbaMedicalCollegeMangalore,Mangalore,IND
4 InternalMedicineand Pediatrics, Kasturba Medical College Mangalore, Mangalore, IND
5 Internal Medicine, Guntur Medical College, Guntur, IND

Corresponding author: Nikhil Chowdary Peddi, nikhilchowdarypeddi@gmail.com

04.04.2022

Диагностическое значение пресепсина как маркера врожденного инфекционного процесса у новорожденных детей

Д.Р. Шарафутдинова1, 2, Е.Н. Балашова1, Ю.В. Сухова1, Ю.В. Кесслер1, А.Р. Киртбая1, 2, А.Ю. Рындин1, 2, Ю.М. Голубцова1, 2, И.А. Шакин1, А.В. Соломонова3, Е.И. Артамкина2, Т.Ю. Иванец1, О.В. Ионов1, 2, В.В. Зубков1, 2

1 ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России, Москва
2 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва
3 ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва

23.03.2022

Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients

Radim Dobiáš 1,2,†, Marcela Kánová 3,4,5,*,†, Nadežda Petejová 6,7,8, Štefan Kis Pisti 9, Robert Bocek 10, Eva Krejcí 1,2, Helena Stružková 2, Michaela Cachová 1, Hana Tomášková 11,12, Petr Hamal 13, Vladimír Havlícek 14,15,† and Milan Raška 16,†.

1 Department of Bacteriology and Mycology, Public Health Institute in Ostrava, 702 00 Ostrava, Czech Republic; radim.dobias@zuova.cz (R.D.); eva.krejci@zuova.cz (E.K.); michaela.cachova@zuova.cz (M.C.)
2 Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic; helcastruzkova@seznam.cz
3 Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, 708 00 Ostrava, Czech Republic
4 Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, 710 00 Ostrava, Czech Republic
5 6 Department of Internal Medicine, University Hospital Ostrava, 708 00 Ostrava, Czech Republic; petejova@seznam.cz
7 Department of Internal Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic
8 Department of Internal Medicine III—Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic
9 Department of Anesthesiology and Resuscitation, Ostrava City Hospital, 728 80 Ostrava, Czech Republic
10 Department of Anesthesiology and Resuscitation, Hospital with Polyclinic Havířov, 736 01 Havířov, Czech Republic
11 Center of Health Services, Institute of Public Health in Ostrava, 702 00 Ostrava, Czech Republic
12 Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic
13 Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic
14 Institute of Microbiology of the Czech Academy of Sciences, 142 20 Prague, Czech Republic
15 Department of Analytical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic
16 Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic

* Correspondence: marcela.kanova@fno.cz

† These authors contributed equally to this work.

12.03.2022

Usefulness of presepsin for the early detection of infectious complications after elective colorectal surgery, compared with C‐reactive protein and procalcitonin

Erika Amanai1, Kishiko Nakai1*, Junichi Saito2, Eiji Hashiba2, Takuya Miura3, Hajime Morohashi3, Yoshiyuki Sakamoto3, Akio Mikami4, Kenichi Hakamada3 & Kazuyoshi Hirota5

1 Department of Anesthesiology, Hirosaki University Hospital, 5 Zaifu-cho, Hirosaki, Aomori 036-8562, Japan.
2 Division of Intensive Care Unit, Hirosaki University Hospital, Hirosaki, Japan.
3 Department of Gastroenterological Surgery and Pediatric Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
4 Central Clinical Laboratory, Hirosaki University Hospital, Hirosaki, Japan.
5 Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

* Email: kishiko_sk1064@hirosaki-u.ac.jp

09.03.2022

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill

Evdoxia Kyriazopoulou 1 and Evangelos J. Giamarellos-Bourboulis 2,*

1 2nd Department of Critical Care Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece; ekyri@med.uoa.gr
2 4th Department of Internal Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece

* Correspondence: egiamarel@med.uoa.gr; Tel.: +30-210-5831994

07.03.2022

A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study

Paola Dell’Aquila1; Pasquale Raimondo2; Daniele Orso3; Paola De Luca1; Pietro Pozzessere1; Carmen Vita Parisi1; Tiziana Bove3; Luigi Vetrugno3; Salvatore Grasso2; Vito Procacci1.

1 Department of Emergency Medicine, University Hospital of Bari, Bari, Italy;
2 Department of Emergency and Organ Transplant, University of Bari Aldo Moro, Bari, Italy;
3 Department of Medicine, University of Udine, Udine, Italy & Department of Anesthesia and Intensive Care Medicine, ASUFC Hospital of Udine, Udine, Italy.

07.03.2022

Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis

Giuseppe Lippi*, Fabian Sanchis-Gomar and Brandon M. Henry

*Corresponding author: Prof. Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, Piazzale L.A. Scuro, 10, 37134 Verona, Italy, Phone: 0039 045 8122970, Fax: 0039 045 8124308, E-mail: giuseppe.lippi@univr.it. https://orcid.org/0000- 0001-9523-9054
Fabian Sanchis-Gomar, Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
Brandon M. Henry, Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

07.03.2022

Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19

Takehiro Hasegawaa, *, Atsushi Nakagawab, Kohjin Suzukic, Kazuto Yamashitad, Saya Yamashitae, Niina Iwanagad, Eiya Tamadad, Kenta Nodad, Keisuke Tomiib

a Sysmex R&D Centre Europe GmbH, Research and Development Division, Falkenried 88, 20251 Hamburg, Germany b Kobe City Medical Centre General Hospital, 2-1-1, Minamimachi, Minatojima, Chuo Ward, Kobe, Japan
c Sysmex System Technology Laboratories, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan
d Sysmex Central Research Laboratories, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan
e Sysmex Business Incubation Department, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan

07.03.2022

Presepsin as a Novel Biomarker in predicting Inhospital Mortality in COVID-19 Pneumonia Patients

Hebatallah Hany Assal*, MD., Hebatallah.Assal@kasralainy.edu.eg, Safaa Abdelrahman, MD., safaa.mohamed5@gmail.com, Maha AlyAlden Abdelbasset, MD., maha.aly@gmail.com, Mai Abdelaziz, MD., maiabdelaziz1979@gmail.com, Irene Mohamed Sabry*, MD., irene.sabry@yahoo.com, Marwa Moawad Shaban*, MD., marwamoawad@ymail.com

Correspondence:
Hebatallah Hany Assal, MD, Hebatallah.Assal@kasralainy.edu.eg, Tel: 01223939861
Address: Department of Chest Medicine, Faculty of Medicine, Cairo University, Al Kasr Al Aini, Old Cairo Cairo,11956, Egypt

23.02.2022

Биомаркеры инфекции в оптимизации антибактериальной терапии: оправданные ожидания

Кулабухов В.В.1, Шабанов А.К.1, Андреева И.В.2, Стецюк О.У.2, Андреев В.А.3

1 НИИ скорой помощи им. Н.В. Склифосовского, Москва, Россия
2 НИИ антимикробной химиотерапии ФГБОУ ВО СГМУ Минздрава России, Смоленск, Россия
3 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

Контактный адрес: Ирина Вениаминовна Андреева, E-mail: Irina.Andreeva@antibiotic.ru

12.01.2022

Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019

F. Linzee Mabrey, MD1, Eric D. Morrell, MD1, Pavan K. Bhatraju, MD, MSc1, Neha A. Sathe, MD1, Sana S. Sakr, PhD1, Sharon K. Sahi, BS1, T. Eoin West, MD, MPH1, Carmen Mikacenic, MD2, Mark M. Wurfel, MD, PhD1
10.12.2021

Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery

Chang Hwan Kim and Eun Young Kim *

Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea;

changhwan.kim0227@gmail.com *

Correspondence: freesshs@naver.com;

13.11.2021

The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review

Chiara Maddaloni 1, Domenico Umberto De Rose 1 , Alessandra Santisi 1, Ludovica Martini 1, Stefano Caoci 1, Iliana Bersani 1, Maria Paola Ronchetti 1,2 and Cinzia Auriti 1,*,†

1 Neonatal Intensive Care Unit (NICU), Medical and Surgical Department of the Fetus—Newborn-Infant, “Bambino Gesù” Children’s Hospital IRCCS, 00165 Rome, Italy; chiara.maddaloni@opbg.net (C.M.); domenico.derose@opbg.net (D.U.D.R.); alessandra.santisi@opbg.net (A.S.); ludovica.martini@opbg.net (L.M.); stefano.caoci@opbg.net (S.C.); iliana.bersani@opbg.net (I.B.); mariapaola.ronchetti@opbg.net (M.P.R.)

2 Neonatal Intensive Care (NICU) and Neonatal Pathology, San Vincenzo Hospital, 98039 Taormina, Italy

Correspondence: cinzia.auriti@opbg.net; Tel.: +39-06-6859-2427; Fax: +39-06-6859-3916
On behalf of the Study Group of Neonatal Infectious Diseases of the Italian Society of Neonatology (SIN)

28.10.2021

Presepsin as a predictor of septic shock in patients with urinary tract infection

Yoshitaka Sekine1*, Kazuhiko Kotani2, Daisuke Oka1, Hiroshi Nakayama1 et al.

1 Department of Urology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi 371-8511, Japan
2 Division of Community and Family Medicine, Department of Clinical Laboratory Medicine, Jichi Medical University, Shimotsuke, Japan.
3 Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

*Correspondence: ysekine@gunma-u.ac.jp

28.10.2021

Perioperative presepsin as a potential early predictor for postoperative infectious complications in cardiac surgery

Hiroto Suzuki1, Hiroto Narimatsu2, Masaki Nakane3, Mitsuaki Sadahiro4, Kaneyuki Kawamae1

1 Department of Anaesthesiology, Yamagata University Faculty of Medicine, Yamagata, Japan
2 Cancer Prevention and Cancer Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan 3Department of Emergency and Critical Care Medicine, Yamagata University Faculty of Medicine, Yamagata, Japan
4 Department of Cardiovascular, Thoracic and Pediatric Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan

26.10.2021

Пресепсин: эффективность мониторинга антибиотикотерапии при сепсисе

Вельков В. В., АО «ДИАКОН», г. Пущино
Октябрь 2021
13.10.2021

Serum level of soluble CD14 subtype predicts long-term prognosis in sepsis patients with cardiac dysfunction

Junliang Liu1, Mingying Dai2, Hongyun Yang3, Lei Song1, Kun Chen4 et al.
1 ICU, Renmin Hospital of Chengyang District, Qingdao, China; 2ICU, Affiliated Hospital of Qingdao University, Qingdao, China; 3ICU, General Hospital of Eastern Theater, Nanjing, China; 4ICU, Guannan Division, The First Renmin Hospital, Lianyungang, China
Contributions: (I) Conception and design: J Liu; (II) Administrative support: M Dai; (III) Provision of study materials or patients: H Yang, L Song; (IV) Collection and assembly of data: K Chen, Y Wang; (V)

Data analysis and interpretation: J Liu, M Hua; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Ming Hua. ICU, Guannan Division, The First Renmin Hospital, Lianyungang 222042, China. Email: hm2000lyg@163.com

10.10.2021

Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review

Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzoet al.

1 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.); marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.); marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)

2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy;
tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)

* Correspondence: michelecosimo.santoro@policlinicogemelli.it
27.09.2021

Presepsin and Procalcitonin as Potential Biomarkers for Early Diagnosis and Prognosis of Sepsis in Critically Ill Patients

Reham Sabry 1, Hend Maghraby Maghraby 2*, Amany Mohamed Abd Allah 2

1 Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
2 Internal Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Email: *drhendms@gmail.com
14.09.2021

Role of Plasma Presepsin, Procalcitonin and C-reactive Protein Levels in Determining the Severity and Mortality of Community-Acquired Pneumonia in the Emergency Department

Izzettin Hur1, Seda Ozkan2;*, Ali Halici3, Kerim Abatay4, Eren Usul5, Esra Cetin6, Fevzi Nuri Aydin6

1 Department of Emergency Medicine, Ministry of Health Pursaklar State Hospital, Ankara, Turkey
2 Department of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
3 Department of Emergency Medicine, Ministry of Health Polatlı State Hospital, Ankara, Turkey
4 Department of Emergency Medicine, Ministry of Health Muş State Hospital, Muş, Turkey
5 Department of Emergency Medicine, Ministry of Health Dr. Nafiz Korez Sincan State Hospital, Ankara, Turkey
6 Department of Clinical Biochemistry, Diskapi Yildirim Beyazit Training & Research Hospital, Ankara, Turkey



Correspondence: sedacil@gmail.com (Seda Ozkan)

14.09.2021

The Effect Of Soluble CD14 Subtype (sCD14ST)/Presepsin And Lactate Clearance On Mortality Status In Pneumonia Patients With Sepsis

Zikanovelia1, Ngakan Putu Parsama Putra1, Yani Jane Sugiri1, Harun Al Rasyid2
1 Department of Pulmonology and Respiration Medicine, Faculty of Medicine, Universitas Brawijaya/ RSUD Dr. Saiful Anwar, Malang
2 Department of Department of Public Health Sciences and Preventive Medicine, Faculty of Medicine, Universitas Brawijaya/RSUD Dr. Saiful Anwar, Malang



Correspondence: Zikanovelia - zikanovelia@gmail.com

02.09.2021

Presepsin as a Predictive Biomarker of Severity in COVID-19: A Systematic Review

Sibtain Ahmed1, Maheen Mansoor2, Muhammad S Shaikh3, Imran Siddiqui4

1,3,4 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
2 Department of Medical College, Aga Khan University, Karachi, Pakistan

Corresponding Author: Sibtain Ahmed, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan, e-mail: sibtain.ahmed@aku.edu
01.09.2021

Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication

Mohamed El-Saied El-Shafiea, Khaled M. Taemaa,❋, Moataz M. El-Hallaga, Abdallah Mohamed Abdallah Kandeelb

aCritical Care Medicine, Cairo University, Egypt
bCritical Care Medicine, El-Sahel Teaching Hospital, Egypt
25.08.2021

Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis

Jong Eun Park1,2,†, Beomki Lee3,†, Sun Joo Yoon4, Chi-Min Park5,6, Chul Won Jung7, Myung-Ju Ahn7,
Hyung-Doo Park3, Sung Yeon Hwang1, Tae Gun Shin1,* and Eun-Suk Kang3,*


1 Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul 06351, Korea; jongeun7.park@samsung.com (J.E.P.); sygood.hwang@samsung.com (S.Y.H.)

2 Department of Emergency Medicine, College of Medicine, Kangwon National University,
Chuncheon 24289, Korea

3 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul 06351, Korea; beomki.lee@skku.edu (B.L.); nayadoo@hanmail.net (H.-D.P.)

4 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea;
yoonsunjoo@gmail.com

5 Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul 06351, Korea; dr99.park@samsung.com

6 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine,
Seoul 06351, Korea

7 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul 06351, Korea; leukemia1@skku.edu (C.W.J.); silk.ahn@samsung.com (M.-J.A.)

* Correspondence: taegunshin@skku.edu (T.G.S.); eskang@skku.edu (E.-S.K.); Tel.: +82-2-3410-2053 (T.G.S.);
+82-2-3410-2703 (E.-S.K.)

These authors contributed equally to this work.
24.08.2021

Usefulness of Presepsin for the Early Detection of Infectious Complications after Elective Colorectal Surgery, Compared with C-Reactive Protein and Procalcitonin

Erika Amanai Hirosaki University Hospital, Kishiko Nakai (kishiko_sk1064@yahoo.co.jp) https://orcid.org/0000-0002-6618-7803, Junichi Saito Hirosaki University Hospital, Eiji Hashiba Hirosaki University Hospital, Takuya Miura Hirosaki University Graduate School of Medicine, Hajime Morohashi Hirosaki University Graduate School of Medicine, Yoshiyuki Sakamoto Hirosaki University Graduate School of Medicine, Akio Mikami Hirosaki University Hospital, Kenichi Hakamada Hirosaki University Graduate School of Medicine, Kazuyoshi Hirota Hirosaki University Graduate School of Medicine.
11.08.2021

The Role and Validity of Diagnostic Biomarkers in Late-Onset Neonatal Sepsis

Patience Mwesigye1, Fizza Rizwan2, Niazy Alassaf3, Rizwan Khan3

1 InternalMedicine,UniversityofLimerick,Limerick,IRL
2 InternalMedicine,MedicalUniversityofSofia,Sofia,BGR
3 Neonatology, University Maternity Hospital, Limerick, Limerick, IRL

Corresponding author: Patience Mwesigye, patiencehonors@gmail.com
30.07.2021

Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review

Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzo2, Gianluca Tullo2, Sara Cicchinelli1, Angela Saviano2, Federico Valletta2, Marco Maria Pascale1, Marcello Candelli1, Marcello Covino1,2 and Francesco Franceschi1,2

1 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy; andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.);
marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.);
marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)

2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)

*Correspondence: michelecosimo.santoro@policlinicogemelli.it
27.07.2021

Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis

Guanghui Zheng1–3,*, Chenxi Zhang1–3,*, Guojun Zhang1–3, Chunqing Shao1–3

1Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital and Capital Medical University, Beijing, People’s Republic of China; 2NMPA Key Laboratory for Quality Control of in vitro Diagnostics, National Medical Products Administration, Beijing, People’s Republic of China; 3Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing Municipal Science and Technology Commission, Beijing, People’s Republic of China

*These authors contributed equally to this work
15.07.2021

COVID-19: гепатобилиарные осложнения: механизмы, биомаркеры, диагноз, прогноз

Вельков В. В., АО «ДИАКОН», г. Пущино
Июль, 2021
15.07.2021

COVID-19: биомаркеры ренальных осложнений, механизмы, диагноз, прогноз

Вельков В. В., АО «ДИАКОН», г. Пущино
Июль, 2021
15.07.2021

COVID-19: сердечно-сосудистые осложнения: механизмы, диагноз, прогноз — роль высокочувствительных тропонинов

Вельков В. В., АО «ДИАКОН», г. Пущино
Июль, 2021
15.07.2021

Осложнения COVID-19: механизмы, биомаркеры, диагноз, прогноз

Вельков В. В., АО «ДИАКОН», г. Пущино
Июль, 2021
23.06.2021

Usefulness of presepsin in predicting the prognosis of patients with sepsis or septic shock: a retrospective cohort study

Jeong Suk Koh, Yoon Joo Kim, Da Hyun Kang, Jeong Eun Lee, Song-I Lee
Department of Pulmonary and Critical Care Medicine, Chungnam National University School of Medicine, Daejeon, Korea
23.06.2021

Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study

Yuichiro Shimoyama1, Osamu Umegaki1, Noriko Kadono1 and Toshiaki Minami2
* Correspondence: shimocchiliebesfreud512@yahoo.co.jp
1 Department of Anesthesiology, Osaka Medical College, Intensive Care Unit, Osaka Medical College Hospital, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
23.06.2021

Presepsin level in predicting patients in-hospital mortality from sepsis under sepsis-3 criteria

Miao-Yun Wen1,*, Lin-Qiang Huang1,*, Fan Yang1,2, Jing-Kun Ye1,3, Geng-Xin Cai1,2, Xu-Sheng Li1,3, Hong-Guang Ding1, Hong-Ke Zeng1
1 Department of Emergency and Critical Care Medicine, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China; 2 School of Medicine, South China University of Technology, Guangzhou, People’s Republic of China; 3The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People’s Republic of China
19.05.2021

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis

Dimitrios Velissaris1, Nicholas Zareifopoulos2, 3, Vasileios Karamouzos4, Evangelos Karanikolas5, Charalampos Pierrakos6, Ioanna Koniari7, Menelaos Karanikolas8

1 Department of Internal Medicine, General University Hospital of Patras, Patras, GRC
2 Department of Psychiatry, General Hospital of Nikaia, Piraeus "Agios Panteleimon", Athens, GRC 3Department of Internal Medicine, University of Patras School of Health Sciences, Patras, GRC
4 Intensive Care Unit, General University Hospital of Patras, Patras, GRC
5 Department of Internal Medicine, University of Patras, Patras, GRC
6 Intensive Care Unit, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, BEL
7 Department of Electrophysiology and Device, University Hospital of South Manchester NHS Foundation Trust, Manchester, GBR
8 Department of Anesthesiology, Washington University School of Medicine, St. Louis, USA

Corresponding author: Nicholas Zareifopoulos, nizareifopoulos@gmail.com

19.03.2021

Novel Diagnostics and Therapeutics in Sepsis

Kieran Leong 1, Bhavita Gaglani 2 , Ashish K. Khanna 2,3, Michael T. McCurdy 1,*

1 Division of Pulmonary & Critical Care, University of Maryland School of Medicine, Baltimore, MD 21201, USA; kleong@som.umaryland.edu
2 Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest University Hospital, Winston-Salem, NC 27157, USA; bgaglani@wakehealth.edu (B.G.); ashish@or.org (A.K.K.)
3 Department of Outcomes Research, Outcomes Research Consortium, Cleveland, OH 44195, USA
* Correspondence: drmccurdy@gmail.com
28.01.2021

Presepsin values and Prognostic Nutritional Index predict mortality in intensive care unit patients with sepsis: a prospective observational study

Yuichiro Shimoyama (  icu003@osaka-med.ac.jp )
Osaka Medical College
Osamu Umegaki
Osaka Medical College: Osaka Ika Daigaku
Noriko Kadono
Osaka Medical College: Osaka Ika Daigaku
Toshiaki Minami
Osaka Medical College: Osaka Ika Daigaku
28.01.2021

Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines

Alice Nicoleta Dragoescu 1, Vlad Padureanu 2,* , Andreea Doriana Stanculescu 1,*, Luminit,a Cristina Chiut,u 1,
Dan Nicolae Florescu 3, Ioana Andreea Gheonea 4, Rodica Padureanu 5 , Alex Stepan 6, Costin Teodor Streba 7,
Andrei Ioan Drocas,
8, Adriana Mihaela Ciocâlteu-Ionescu 3, Valeriu MarinS,
urlin 9 and Octavian
Petru Dragoescu 8

Department of Anesthesiology and Intensive Care, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; alice.dragoescu@yahoo.com (A.N.D.); luminita.chiutu@gmail.com (L.C.C.)
2 Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3 Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
nicku_dan@yahoo.co.uk (D.N.F.); adriana_ciocalteu@yahoo.com (A.M.C.-I.)
4 Department of Radiology and Medical Imaging, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; iagheonea@gmail.com
5 Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
zegheanurodica@yahoo.com
6 Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
astepan76@yahoo.com
7 Department of Research Methodology, University of Medicine and Pharmacy of Craiova, 200349 Craiova,
Romania; costinstreba@gmail.com
8 Department of Urology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania;
andrei_drocas@yahoo.com (A.I.D.); pdragoescu@yahoo.com (O.P.D.)
9 Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
vsurlin@gmail.com
* Correspondence: vldpadureanu@yahoo.com (V.P.); stanculescu.andreea@yahoo.com (A.D.S.)
28.01.2021

Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients

Elham A. Hassan 1,*, Abeer S. Abdel Rehim 1, Asmaa O. Ahmed 2, Hanan Abdullahtif 2 and
Alaa Attia 3
1 Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University,
Assiut 71111, Egypt; sharafabeer@yahoo.com
2 Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
asomar_12@yahoo.com (A.O.A.); Abdlatif@aun.edu.eg (H.A.)
3 Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
alaa.atya@med.au.edu.eg
* Correspondence: mam_elham75@yahoo.com; Tel.: +201002963415; Fax: +20882333327
28.01.2021

Диагностические маркеры раннего неонатального сепсиса – ограничения и перспективы

О. Н. ИВАНОВА1,2, Е. В. ГРИГОРЬЕВ1
1Кемеровский государственный медицинский университет МЗ РФ, г. Кемерово, РФ
2Кемеровская областная клиническая больница, г. Кемерово, РФ
28.01.2021

The Utility of Neutrophil CD64 and Presepsin as Diagnostic, Prognostic, and Monitoring Biomarkers in Neonatal Sepsis

Heba E. Hashem ,1 Rania M. Abdel Halim,1 Sherin A. El Masry ,1 Amira M. Mokhtar ,1
and Noureldin M. Abdelaal 2
1Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2Pediatric and Neonatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Correspondence should be addressed to Heba E. Hashem; hebaezzat@med.asu.edu.eg
Received 9 July 2020; Revised 16 August 2020; Accepted 22 September 2020; Published 2 November 2020
28.01.2021

Диагностическое и прогностическое значение уровня пресепсина при инфекционно-воспалительных заболеваниях у недоношенных новорожденных

Л.Н. Журавлева, В.И. Новикова
Витебский государственный медицинский университет
Diagnostic and prognostic value of the presepsin level in inflammatory infectious
diseases in preterm newborns
L.N. Zhuravleva, V.I. Novikova
Vitebsk State Medical University, Vitebsk, Belarus
27.01.2021

Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis

Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,
Chih‑Huang Li3, Gerald N. Blaney III1, Zhen‑Ying Liu1 and Kuan‑Fu Chen1,3,6,7*

*Correspondence: drkfchen@gmail.com
6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
27.01.2021

Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines

Alice Nicoleta Dragoescu 1, Vlad Padureanu 2,* , Andreea Doriana Stanculescu 1,*, Luminit,a Cristina Chiut,u 1,
Dan Nicolae Florescu 3, Ioana Andreea Gheonea 4, Rodica Padureanu 5 , Alex Stepan 6, Costin Teodor Streba 7,
Andrei Ioan Drocas,
8, Adriana Mihaela Ciocâlteu-Ionescu 3, Valeriu MarinS,
urlin 9 and Octavian
Petru Dragoescu 8


1 Department of Anesthesiology and Intensive Care, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; alice.dragoescu@yahoo.com (A.N.D.); luminita.chiutu@gmail.com (L.C.C.)
2 Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3 Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
nicku_dan@yahoo.co.uk (D.N.F.); adriana_ciocalteu@yahoo.com (A.M.C.-I.)
4 Department of Radiology and Medical Imaging, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; iagheonea@gmail.com
5 Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
zegheanurodica@yahoo.com
6 Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
astepan76@yahoo.com
7 Department of Research Methodology, University of Medicine and Pharmacy of Craiova, 200349 Craiova,
Romania; costinstreba@gmail.com
8 Department of Urology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania;
andrei_drocas@yahoo.com (A.I.D.); pdragoescu@yahoo.com (O.P.D.)
9 Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
vsurlin@gmail.com
* Correspondence: vldpadureanu@yahoo.com (V.P.); stanculescu.andreea@yahoo.com (A.D.S.)
27.01.2021

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis

Yutaka Kondo1†, Yutaka Umemura2†, Kei Hayashida3†, Yoshitaka Hara4, Morio Aihara5 and Kazuma Yamakawa6

†Yutaka Kondo, Yutaka Umemura and Kei Hayashida contributed equally to
this work.
6Division of Trauma and Surgical Critical Care, Osaka General Medical Center,
3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan
Full list of author information is available at the end of the article
27.01.2021

Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis

Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,
Chih‑Huang Li3, Gerald N. Blaney III1, Zhen‑Ying Liu1 and Kuan‑Fu Chen1,3,6,7

*Correspondence: drkfchen@gmail.com
6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
27.01.2021

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis

Ying Zhu1,2
Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
Tianzhu Tao4

1Department of Respiratory Medicine,
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Republic of China; 2Department of
Respiratory and Critical Care Medicine,
Shanghai East Hospital, Tongji University,
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic of
China; 4Department of Anesthesiology,
Air Force Medical Center, PLA, Beijing,
People’s Republic of China
23.10.2020

Пресепсин как маркер неонатального сепсиса: диагностика, прогноз, мониторинг

Вельков В.В., АО «ДИАКОН», г. Пущино

Конгресс памяти академика Б.Р. Гельфанда
«Сепсис. Кровотечения. Тромбозы.
Междисциплинарный подход».
Москва, 7
8 (9) ноября 2020 г.
08.10.2020

IFCC interim guidelines on biochemical hematological monitoring of COVID-19 patients




29.09.2020

Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients

Ahmed M. El Saida, Akram M. Fayed b and Ehab M. El-Rewenyb

Department of Critical Care Medicine, Alexandria Armed Forces Hospital, Alexandria, Egypt; bDepartment of Critical Care Medicine,
Faculty of Medicine, Alexandria University, Alexandria, Egypt
29.09.2020

Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C - reactive protein as biomarkers for early diagnosis of paediatric sepsis

Samuel Asamoah Sakyi a,*, Anthony Enimil b, David Kwabena Adu a,c, Richard Dadzie Ephraim d,
Kwabena Owusu Danquah e, Linda Fondjo a, David Baidoe-Ansah f, Prince Adoba a,
Emmanuel Toboh g, Bright Oppong Afranie

a Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
b Child Health Directorate, Komfo Anokye Teaching Hospital, School of Medical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi,
Ghana
c College of Health and Well-Being, Kintampo, Ghana
d Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana
e Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
f Department of Physiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
g Laboratory Diagnostics, Ghana Health Service, Dansoman Polyclinic, Accra, Ghana
29.09.2020

Association between elevation of plasma biomarkers and monocyte dysfunction and their combination in predicting sepsis: An observational single-centre cohort study

Jiabao Li1, Ziren Tang1, Miaorong Xie2, Chenchen Hang1,
Yanan Yu1 and Chunsheng Li1

1Department of Emergency Medicine, Beijing Chaoyang Hospital, Capital
Medical University, PR China
2Department of Emergency Medicine, Beijing Friendship Hospital, Capital
Medical University, PR China


29.09.2020

Presepsin values and Prognostic Nutritional Index predict mortality in intensive care unit patients with sepsis: a prospective observational study

Yuichiro Shimoyama ( icu003@osaka-med.ac.jp )
Osaka Medical College
Osamu Umegaki
Osaka Medical College: Osaka Ika Daigaku
Noriko Kadono
Osaka Medical College: Osaka Ika Daigaku
Toshiaki Minami
Osaka Medical College: Osaka Ika Daigaku

29.09.2020

Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker

Yusuke Koizumi1,2* , Daisuke Sakanashi2, Tetsuo Mohri2, Hiroki Watanabe1,2, Arufumi Shiota2, Nobuhiro Asai1,2,
Hideo Kato2, Mao Hagihara2, Kenta Murotani3, Yuka Yamagishi1,2, Hiroyuki Suematsu2 and Hiroshige Mikamo1,2

* Correspondence: ykoizumi@aichi-med-u.ac.jp
1Department of Clinical Infectious Diseases, Aichi Medical University Hospital,
1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan
2Department of Infection Control, Aichi Medical University Hospital,
Nagakute, Aichi, Japan


29.09.2020

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1

1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article


29.09.2020

Presepsin values as markers of severity of sepsis

Ajete Aliu-Bejtaª٭, Anita Ateljᵇ, Mentor Kurshumliu ,ͨ Shemsedin Dreshajª, Bruno Baršićᵇ
٭
ª ICU Department, University Clinic of Infectious Diseases, Alexander Flemingu, 10000 Pristina, Kosovo
ᵇ ICU Department, University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Mirogojska 8,
10000 Zagreb, Croatia
28.09.2020

Role of Plasma Presepsin, Procalcitonin and C-reactive Protein Levels in Determining the Severity and Mortality of Community-Acquired Pneumonia in the Emergency Department

Izzettin Hur1, Seda Ozkan2;*, Ali Halici3, Kerim Abatay4,
Eren Usul5, Esra Cetin6, Fevzi Nuri Aydin6


1Department of Emergency Medicine,
Ministry of Health Pursaklar State
Hospital, Ankara, Turkey
2Department of Emergency Medicine,
Cerrahpasa Faculty of Medicine, Istanbul
University-Cerrahpasa, Istanbul, Turkey
3Department of Emergency Medicine,
Ministry of Health Polatlı State Hospital,
Ankara, Turkey
4Department of Emergency Medicine,
Ministry of Health Muş State Hospital,
Muş, Turkey
5Department of Emergency Medicine,
Ministry of Health Dr. Nafiz Korez Sincan
State Hospital, Ankara, Turkey
6Department of Clinical Biochemistry,
Diskapi Yildirim Beyazit Training &
Research Hospital, Ankara, Turkey


28.09.2020

Discriminatory ability and prognostic evaluation of presepsin for sepsis-related acute respiratory distress syndrome

Jiangnan Zhao1, Yan Tan2, Li Wang2 & Yi Shi1
28.09.2020

Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia

Motoi Ugajin1, Yu Matsuura2, Kei Matsuura2, Hiroshi Matsuura2


1Department of Respiratory Medicine, 2Department of Internal Medicine, Nagoya Tokushukai General Hospital, Kasugai City, Aichi Prefecture,
Japan
Contributions: (I) Conception and design: M Ugajin; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors;
(IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: M Ugajin; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Motoi Ugajin, MD. Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai
City 487-0016, Japan. Email: ugarin2001@yahoo.co.jp.
28.09.2020

Presepsin as a biomarker in perioperative medicine

Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,
Simonetta TESORO 3, Edoardo DE ROBERTIS 3

1Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany; 2Department of Medicine
and Surgery, University of Salerno, Baronissi, Salerno, Italy; 3Department of Surgical and Biomedical Sciences,
University of Perugia, Perugia, Italy
28.09.2020

The novel early predictive marker presepsin for postoperative pancreatic fistula: A pilot study

MASATSUGU HIRAKI1, ATSUSHI MIYOSHI1, EIJI SADASHIMA2, YUKIO SHINKAI3, MICHIO YASUNAMI3, TATSUYA MANABE4, KENJI KITAHARA1 and HIROKAZU NOSHIRO4

1Department of Surgery; 2Life Science Research Institution; 3Clinical Laboratory, Saga Medical Center Koseikan, Saga 840‑8571; 4Department of Surgery, Saga University Faculty of Medicine, Saga 849‑8501, Japan
28.09.2020

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1*

1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
28.09.2020

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli



07.09.2020

Осложнения COVID-19: механизмы, биомаркеры, экспресс-диагностика




21.08.2020

Опыт использования пресепсина в неонатальной практике

Козлова Е.М., Шунькина Г.Л., Чумак Н.М.,
Суслова М.А.


05.08.2020

Role of Plasma Presepsin, Procalcitonin and C-reactive Protein Levels in Determining the Severity and Mortality of Community-Acquired Pneumonia in the Emergency Department

Izzettin Hur1, Seda Ozkan2;*, Ali Halici3, Kerim Abatay4,
Eren Usul5, Esra Cetin6, Fevzi Nuri Aydin6

1Department of Emergency Medicine,
Ministry of Health Pursaklar State
Hospital, Ankara, Turkey
2Department of Emergency Medicine,
Cerrahpasa Faculty of Medicine, Istanbul
University-Cerrahpasa, Istanbul, Turkey
3Department of Emergency Medicine,
Ministry of Health Polatlı State Hospital,
Ankara, Turkey
4Department of Emergency Medicine,
Ministry of Health Muş State Hospital,
Muş, Turkey
5Department of Emergency Medicine,
Ministry of Health Dr. Nafiz Korez Sincan
State Hospital, Ankara, Turkey
6Department of Clinical Biochemistry,
Diskapi Yildirim Beyazit Training &
Research Hospital, Ankara, Turkey
*Correspondence
sedacil@gmail.com
(Seda Ozkan)
29.07.2020

Presepsin as a biomarker in perioperative medicine

Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,
Simonetta TESORO 3, Edoardo DE ROBERTIS 3

1Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany; 2Department of Medicine
and Surgery, University of Salerno, Baronissi, Salerno, Italy; 3Department of Surgical and Biomedical Sciences,
University of Perugia, Perugia, Italy
28.07.2020

Диинамика пресепсина при мониторинге эффективности терапии COVID-19 с помощью препарата favipiravir

Hitoshi Yamamura* , Hiroshi Matsuura, Junichiro Nakagawa, Hiroshi Fukuoka, Hisaya Domi and Satoru Chujoh

28.07.2020

Presepsin as a Biomarker for Sepsis Evolutions in Diabetis

EOSEFINA GINA BOTNARIU1, NORINA CONSUELA FORNA2, ALINA DELIA POPA3*, ILEANA ANTOHE3, CRISTINA LACATUSU1, BOGDAN MIHAI1

1 “Grigore T. Popa” University of Medicine and Pharmacy, Department of Diabetes, Nutrition and Metabolic Disease, Medical Sciences, 16 Universitatii Str, 700115, Iasi, Romania, 2 “Grigore T. Popa” University of Medicine and Pharmacy, Faculty of Dentistry, Department of Oral Implantology and Prostodontics, 16 Universitatii Str, 700115,Iasi, Romania 3 “Grigore T. Popa” University of Medicine and Pharmacy, Discipline of Nursing,16 Universitatii Str, 700115, Iasi,  Romania

10.07.2020

Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients

Ahmed M. El Said , Akram M. Fayed & Ehab M. El-Reweny

To cite this article: Ahmed M. El Said , Akram M. Fayed & Ehab M. El-Reweny (2020)
Comparative study between complete blood picture indices and presepsin as early prognostic
markers in septic shock patients, Egyptian Journal of Anaesthesia, 36:1, 118-125, DOI:
10.1080/11101849.2020.1789403


08.07.2020

Осложнения COVID-19: механизмы, биомаркеры, риски

Вельков В.В, АО «ДИКОН», г. Пущино, Московская область
07.07.2020

Отчет об оценке клинической значимости лабораторного маркера Пресепсина для диагностики сепсиса у пациентов с COVID-19

Отчет о клинико-лабораторном исследовании.
Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского.
02.07.2020

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1*

* Correspondence: JGAHN@yuhs.ac
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
02.07.2020

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli
01.07.2020

Presepsin Level Correlates with the Development of Moderate Coronary Artery Calcifications in Hemodialysis Patients: A Preliminary Cross-Section Design Study

Ahmed F Elhabashi
Leena Sulaibeekh
Nahed Seddiq
Salman Alali
Amjad K Abdulmajeed
Nuria S Perez

Bahrain Defense Force Hospital, Royal
Medical Services, Riffa, Kingdom of
Bahrain
01.07.2020

Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis

Wuqiong Zhou MD,1# Heping Rao PhD,2# Qiuming Ding MD,1* Xiang Lou MMS,1
Jianjiang Shen MPH,1 Bin Ye MD,3 Caixia Xiang PhD4
01.07.2020

Presepsin values as markers of severity of sepsis

Ajete Aliu-Bejtaª٭, Anita Ateljᵇ, Mentor Kurshumliu ,ͨ Shemsedin Dreshajª, Bruno Baršićᵇ٭

ª ICU Department, University Clinic of Infectious Diseases, Alexander Flemingu, 10000 Pristina, Kosovo
ᵇ ICU Department, University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Mirogojska 8,
10000 Zagreb, Croatia
ͨ “PROLAB” Biochemical Laboratory, Mark Dizdari, 10000 Pristina, Kosovo
٭Correspondence: ajete.aliu@gmail.com (Ajete Aliu-Bejta), barsicbruno@gmail.com (Bruno Baršić)

30.06.2020

Diagnostic Value of Presepsin for Bacterial Infection in Cirrhosis: A Pilot Study

Simone Novellia, *, Vincenzo Morabitob , Franco Rubertob , Fabiano Binib , Franco Marinozzib , Francesco Puglieseb , Pasquale Berlocob , and Renzo Pretagostinib a Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Rome, Italy; and b Department of General Surgery and Organ Transplantation, Sapienza University of Rome, Rome, Italy
30.06.2020

Presepsin as a predictive biomarker of severity in COVID-19: a case series

Ai Fukada1, Yutaro Kitagawa1, Masaru Matsuoka1, Jun Sakai2, Kazuo Imai2
Tarumoto Norihito2, Yuta Orihara1, Rieko Kawamura1, Shinichi Takeuchi1
Shigefumi Maesaki2, Takuya Maeda1, 3
1Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan
2 Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan
3Department of Laboratory Medicine, Saitama Medical University, Saitama, Japan
28.04.2020

Роль пресепсина в диагностике и оценке тяжести течения сепсиса и тяжелой пневмонии

Е.А. Титова 1) А.Р. Эйрих 2) З.А. Титова 3)

1) ФГБОУ ВО "Алтайский государственный медицинский университет"
2) КГБУЗ "Краевая клиническая больница", Барнаул, Россия
28.04.2020

Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia

Zhi-jiang Qia,1, Han Yua,1, Jing Zhangb, Chun-sheng Lia,⁎
a Emergency Department of Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
b Emergency Department of Beijing Tuberculosis Research Institute, Capital Medical University, Beijing 101149, China
28.04.2020

PRESEPSIN AND PROCALCITONIN – MARKERS OF SEPSIS AND SEVERE PNEUMONIA

1Altai State Medical University, Barnaul
2Regional Clinical Hospital, Barnaul
Ye.A. Titova1, Ye.M. Reutskaya2, Z.A. Titova1, S.I. Kytmanova2, Ye.M. Petayeva2, A.R. Eirikh2
28.04.2020

Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia

Motoi Ugajin1, Yu Matsuura2, Kei Matsuura2, Hiroshi Matsuura2
1Department of Respiratory Medicine, 2Department of Internal Medicine, Nagoya Tokushukai General Hospital, Kasugai City, Aichi Prefecture,
Japan
Contributions: (I) Conception and design: M Ugajin; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors;
(IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: M Ugajin; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Motoi Ugajin, MD. Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai
City 487-0016, Japan. Email: ugarin2001@yahoo.co.jp.
28.04.2020

A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores

Ji Yeon Ham, MD, Kyung Eun Song, MD, PhD*
Laboratory Medicine 2019;XX:0–0
DOI: 10.1093/labmed/lmz005
28.04.2020

Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department

Emergency Department, Beijing Chao-Yang Hospital of the Capital Medical University,
Beijing 100020, China
Received 29 January 2014; accepted 6 May 2014
Available online 2 June 2014
28.04.2020

Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia

Motoi Ugajin1, Yu Matsuura2, Kei Matsuura2, Hiroshi Matsuura2
1Department of Respiratory Medicine, 2Department of Internal Medicine, Nagoya Tokushukai General Hospital, Kasugai City, Aichi Prefecture,
Japan
Contributions: (I) Conception and design: M Ugajin; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors;
(IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: M Ugajin; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Motoi Ugajin, MD. Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai
City 487-0016, Japan. Email: ugarin2001@yahoo.co.jp.
28.04.2020

The role of presepsin in the diagnosis of chronic obstructive pulmonary disease acute exacerbation with pneumonia

Ali Halıcı1, I˙zzettin Hu¨ r1, Kerim Abatay1, Esra C¸ etin2, Filiz Halıcı3 & Seda O¨ zkan*,4
1Department of Emergency Medicine, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital,
06145, Ankara, Turkey
2Department of Biochemistry, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital, 06145, Ankara,
Turkey
3Department of Family Medicine, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital,
06145, Ankara, Turkey
4Department of Emergency Medicine, University of Istanbul-Cerrahpasa, Faculty of Medical, 34098, Istanbul, Turkey
*Author for correspondence: Tel.: +90 212 414 3434; sedacil@gmail.com
27.04.2020

Динамика пресепсина при развитии инфекции COVID-19

COVID-19 におけるプレセプシンの有用性
埼玉医科大学病院 中央検査部2)同 感染症科・感染制御科
27.04.2020

Пресепсин и стратификация рисков у пациентов с SARS-CoV-2​ (COVID-19)

Presepsin in risk stratification of SARS-CoV-2 patients
Clinica Chimica Acta Available online 22 April 2020
Martina Zaninotto aMonica Maria Mion aChiara Cosmaa Daniela Rinaldi aMarioPlebaniab
https://doi.org/10.1016/j.cca.2020.04.020Get rights and content
14.04.2020

Анализатор PATHFAST: Диагностика и мониторинг осложнений, связанных с инфекцией COVID-19

07.04.2020

Лабораторные нарушения у пациентов с инфекцией COVID-2019

Giuseppe Lippi/ Марио Плебани Опубликовано: 2020-03-03 J Clin Chem Lab Med / DOI: https://doi.org/10.1515/cclm-2020-0198
07.04.2020

Кампания Выживем При Сепсисе: Руководство по ведению критически больных взрослых с коронавирусной болезнью 2019 (COVID-19)

Перевод В.С. Гороховского, М.Б. Куцего, А.А. Науменко, В.Д. Охотника, И.Р. Черкашиной

COVID2019 Khabarovsk2 (2).jpg
16.03.2020

Пресепсин: ранний и высокоспецифичный маркер сепсиса: значение для неонатологии

Вельков В.В., АО «ДИАКОН»
12.03.2020

Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis

Mitsuhiro Tambo*, Satoru Taguchi, Yu Nakamura, Takatsugu Okegawa and Hiroshi Fukuhara

* Correspondence: tanbodes@ks.kyorin-u.ac.jp
Department of Urology, Kyorin University School of Medicine, Shikawa
6-20-2, Mitaka, Tokyo 181-8611, Japan
25.02.2020

Discriminatory ability and prognostic evaluation of presepsin for sepsis-related acute respiratory distress syndrome

Jiangnan Zhao
Department of Respiratory and Critical Medicine
Yan Tan
Department of Respiratory Medicine
Li Wang
Department of Respiratory Medicine
25.02.2020

Presepsin as a New Marker for Early Detection Neonatal Sepsis in Al-Quwayiyah General Hospital Riyadh, KSA

Enas Sh. Khater1,2* and Taha M. Al-Hosiny3,4

1Department of Microbiology and Immunology, Faculty of Medicine, Benha University, Egypt.
2Microbiology Laboratory, Al-Quwayiyah General Hospital, Riyadh, KSA.
3Department of Pediatrics, Faculty of Medicine, Benha University, Egypt.
4Nursery Department, Al-Quwayiyah General Hospital, Riyadh, KSA.а
13.02.2020

Современный взгляд на биомаркеры воспаления у новорожденных детей

Т.Н. Войтович, Ю.А. Устинович, А.К. Дигоева
г. Минск, УО «Белорусский государственный медицинский университет»
17.12.2019

Пресепсин и маркеры воспаления при инфекциях ЦНС

Абудеев С.А.

Клуб РуНейро
При поддержке компании «Диакон»


16.12.2019

Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan

Yoshiro Imai,1,2 Kohei Taniguchi ,2 Ryo Iida,1 Masahiko Nitta,1
Kazuhisa Uchiyma,2 Akira Takasu1
04.12.2019

Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice

Matjaz Jereb1, Matej Mavric1, Miha Skvarc2, Alja Drobnic1, Spela Dolenc1, Natalija Planinc Strunjas1, Boris Luksic3, Nina Grasselli Kmet1
1 Department of Infectious Diseases, University Medical Centre, Ljubljana, Slovenia
2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
3 Department of Infectious Diseases, Clinical Hospital Center, Split, Croatia
28.11.2019

Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?

Petra Fischera, Crina Grigorasa, Anca Bugariua, Oana Nicoara-Farcaua, Horia Stefanescub,
Andreea Beneab, Adina Hadadec, Simona Margaritc, Zeno Sparcheza,b, Marcel Tantaua,b,
Daniela Ionescuc,d,1, Bogdan Procopeta,b,∗,1
a University of Medicine and Pharmacy “Iuliu Hatieganu”, 3rd Medical Clinic, Hepatology Department, Cluj-Napoca, Romania
b Regional Institute of Gastroenterology and Hepatology “Prof. Dr. Octavian Fodor”, Hepatology Department, Cluj-Napoca, Romania
c University of Medicine and Pharmacy “Iuliu Hatieganu”, Department of Anesthesia and Intensive Care I, Cluj-Napoca, Romania
d Outcome Research Consortium, Cleveland, USA
26.11.2019

Современные биомаркеры инфекций и септических осложнений и методы их лабораторной диагностики

Вельков В.В., АО "Диакон", 2018


25.11.2019

The value of serum presepsin in differentiating Gram-negative bacteria from Gram-positive bacteria and fungal infection in sepsis patients

Ye Zhihui1, Ding Hongguang2, Ye Jingkun2, Cai Gengxin2, Zeng Hongke2, Wen Miaoyun2

1Emergency Department,Longgang District Central Hospital of Shen Zhen,Shen Zhen 518116,China;
2Department of Emergency and Critical Care Medicine, Guangdong Provincial People’s Hospital and
Guangdong Academy of Medical Sciences, Guangzhou 510080, China
Corresponding author:Wen Miaoyun, Email: wenmiaoyun041105@163.com
05.11.2019

Пресепсин: результаты российских исследований 2013 – 2019

АО «ДИАКОН», 2019
05.11.2019

Changes of Early Sepsis Biomarker Presepsin Level during Hemodialysis: Influence of β2-Microglobulin Clearance of Dialysis Membrane: A Preliminary Study

Jun Shiota
Department of Internal Medicine, Tsunashima Kidney Clinic, Yokohama, Japan
05.11.2019

Prediction of presepsin concentrations through commensurate decline in kidney function in the elderly

Seiji Kobayashia,b,⁎, Hoichi Amanob,c, Hiroyuki Terawakid, Yoshindo Kawaguchib,
Takashi Yokoob
05.11.2019

Serum biomarkers in the diagnosis of periprosthetic joint infection: consolidated evidence and recent developments

G. VICENTI1, D. BIZZOCA1, V. NAPPI1, V. PESCE1, G. SOLARINO1, M. CARROZZO1,
F. MORETTI2, F. DICUONZO3, B. MORETTI1
05.11.2019

An evaluation of clinical inflammatory and coagulation markers in patients with sepsis: a pilot study


Emi Fujii, Kazunori Fujino, and Yutaka Eguchi
Department of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
05.11.2019

The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review

Lin Ruan1*, Guan-Yu Chen1, Zhen Liu1,2†, Yun Zhao1,2†, Guang-Yu Xu1,2†, Shu-Fang Li1,2†, Chun-Ni Li1,2†,
Lin-Shan Chen1,3† and Zheng Tao1,3†
05.11.2019

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis

Yutaka Kondo1†, Yutaka Umemura2†, Kei Hayashida3†, Yoshitaka Hara4, Morio Aihara5 and Kazuma Yamakawa6
05.11.2019

Цистатин С – биомаркер для дифференциальной диагностики гломерулярной и тубулярной дисфункции при развитии острого повреждения почек, связанного с хирургией и сепсисом

Вельков В.В., АО «ДИАКОН», 2019
10.10.2019

Роль биохимических маркеров воспаления у пациентов с нейтропенией после химиотерапии

Ю.Н. Дубинина1, В.О. Саржевский2, В.Я. Мельниченко2

1 Клиника амбулаторной онкологии и гематологии, ул. Молодогвардейская, д. 2, корп. 1, Москва, Российская Федерация, 121467
2 ФГБУ «Национальный медико-хирургический центр им. Н.И. Пиро-
гова», Минздрава России, ул. Нижняя Первомайская, д. 70, Москва,
Российская Федерация, 105203

10.10.2019

Sepsis diagnosis and monitoring – procalcitonin as standard, but what next?

Magdalena Mierzchała-Pasierb, Department of Medical
Biochemistry, Wroclaw Medical University,
10 Chalubinskiego St., 50-368 Wroclaw, Poland,
e-mail: magdalena.mierzchala-pasierb@umed.wroc.pl
16.09.2019

Пресепсин – биомаркер сепсиса и тяжелых инфекций: ранняя диагностика, прогноз, мониторинг

Вельков В.В., АО «ДИАКОН, г. Пущино, Московская область

10.09.2019

Clinical evaluation of presepsin considering renal function

Masashi MiyoshiID
1*, Yusuke Inoue1, Mai Nishioka1, Akishige Ikegame1, Takayuki Nakao1,
Seiji Kishi2, Toshio Doi2, Kojiro Nagai2*
1 Department of Medical Technology, Tokushima University Hospital, Tokushima, Japan, 2 Department of
Nephrology, Tokushima University Hospital, Tokushima, Japan

09.09.2019

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1

* Correspondence: JGAHN@yuhs.ac
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article

30.08.2019

Presepsin as a predictor of sepsis outcome in comparison with procalcitonin and C-reactive protein

Amr M. Mahmouda, Hossam M. Sherifb, Hamdy M. Sabera, Khaled M. Taemab

Critical Care Medicine Department, Beni Suef
University, Beni Suef, bCritical Care Medicine
Department, Cairo University, Giza, Egypt
Correspondence to Khaled M. Taema, MD,
7985 Almadeena Almonawara Street,
Mokattam, Cairo 11571, Egypt.
Tel: +20 100 041 2603;
e-mail: khaled.toaima@kasralainy.edu.eg


19.08.2019

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli
14.08.2019

Пресепсин – ранний маркер септических осложнений при хирургии, эндопротезировании, политравмах и ожогах

Вельков В.В., АО «ДИАКОН», 2019
14.08.2019

Пресепсин: диагностика и мониторинг инфекционных осложнений онкологических заболеваний

Вельков В.В., АО «ДИАКОН», 2019
14.08.2019

Сепсис-2, Сепсис-3 и тяжелые инфекции: диагностическое значение пресепсина

Вельков В.В., АО «ДИАКОН», 2019
14.08.2019

Септическое острое повреждение почек: ранняя комплексная диагностика сепсиса и гломерулярной и тубулярной дисфункции

Вельков В.В., АО «ДИАКОН», 2019
14.08.2019

Современная лабораторная диагностика критических состояний: сепсис и острое повреждение почек: С-реактивный белок, прокальцитонин, пресепсин, цистатин С

Вельков В.В., АО «ДИАКОН», 2019
07.08.2019

Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates

Halil Değirmencioğlu1, Buse Ozer Bekmez2* , Turan Derme2, Mehmet Yekta Öncel3, Fuat Emre Canpolat2 and
Cüneyt Tayman2

Диагностические характеристики пресепсина при позднем неонатальном сепсисе у недоношенных новорожденных.
Пограничный уровень -  823  пг/мл
Чувствительность – 88,9%; специфичность – 88,9%,  AUC ROC – 0,939;
Положительное предиктивное значение – 72,7%
Отрицательное предиктивное значение -  87,5 %

31.07.2019

Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria

Miao-Yun Wen1,*
Lin-Qiang Huang1,*
Fan Yang1,2
Jing-Kun Ye1,3
Geng-Xin Cai1,2
Xu-Sheng Li1,3
Hong-Guang Ding1
Hong-Ke Zeng1

1Department of Emergency and Critical
Care Medicine, Guangdong Provincial
People’s Hospital and Guangdong
Academy of Medical Sciences,
Guangzhou, People’s Republic of China;
2School of Medicine, South China
University of Technology, Guangzhou,
People’s Republic of China; 3The Second
School of Clinical Medicine, Southern
Medical University, Guangzhou, People’s
Republic of China

*These authors contributed equally to
this work
31.07.2019

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis

Ying Zhu1,2
Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
Tianzhu Tao4

1Department of Respiratory Medicine,
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Republic of China;
2Department of Respiratory and Critical Care Medicine,
Shanghai East Hospital, Tongji University,
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic ofChina;
4Department of Anesthesiology,
Air Force Medical Center, PLA, Beijing,
People’s Republic of China
17.07.2019

Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis

Deepak P. Venugopalan , Gopalakrishna Pillai , Sajitha Krishnan
1. Internal Medicine, Aster Medcity, Kochi, IND 2. Internal Medicine, Amrita Institute of Medical
Sciences and Research Centre, Kochi, IND
 Corresponding author: Deepak P. Venugopalan, drdeepakvenugopalan@gmail.com
Disclosures can be found in Additional Information at the end of the article
12.07.2019

Сравнительная оценка активности эндотоксина и (точности) различных биомаркеров (ПСП, ПКТ, лактат, ИЛ-6) по отношению к инфекциям и исходам у пациентов, поступивших в отделение неотложной терапии

Toshiaki Ikeda 1,*, Hidenobu Kamohara 1, Shingo Suda 1, Takeo Nagura 1, Mikiko Tomino 2,
Masatoshi Sugi 2 and Zen’ichiro Wajima 2
1 Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center,
Tokyo 193-0998, Japan
2 Department of Anesthesiology, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
* Correspondence: toshi@tokyo-med.ac.jp; Tel.: +81-426-65-5611
11.07.2019

Новые возможности диагностики и интенсивной терапии сепсиса

Звягин А.А., Демидова В.С., Терехова Р.П.,
Институт хирургии им. А.В. Вишневского, Москва
10.07.2019

Пресепсин - новый маркер сепсиса: значение для неонатологии, обзор международных и отечественных клинических испытаний

Вельков В.В., АО «ДИАКОН», г. Пущино, Московская область.
03.07.2019

Change in the presepsin level in hemodialysis patients with pneumonia and sepsis

1 Altai State Medical University, Barnaul
2 Regional Clinical Hospital, Barnaul
E.A. Titova1, A.R. Eirikh2, Z.A. Titova1, O.G. Zhgut2, S.I. Ivanova2, T.N. Zateeva2, D.V. Petrova2, E.M.
Reutskaya2
24.06.2019

Utility of Presepsin for Diagnosis of Infected Acute Necrotizing Pancreatitis

Oleksandr Rotar1, Igor Khomiak2, Michail Nazarchuck3, Vasyl Rotar1, Andrii Khomiak2, Krishna
Taneja1, Sitlana Railianu1
1Bukovinian State Medical University, Chernivtsi, Ukraine
2O.O. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine
35th City Clinical Hospital, Minsk, Belarus
05.06.2019

Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis

Iris van Maldeghem , Charlotte M. Nusman and Douwe H. Visser
1Department of Pediatrics, Emma Children’s Hospital, Amsterdam UMC,
University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
Full list of author information is available at the end of the article.

«Пресепсин (sCD14-ST) как биомаркер раннего и позднего неонатального сепсиса: систематический обзор и мета-анализ» ПСП – многообещающий маркер раннего и позднего неонатального сепсиса (РНС и ПНС). Разница между средними уровнями ПСП при РНС и ПНС подчеркивает важность того, что РНС и ПНС это две различные патологические сущности (different disease entities), при которых образцы измеренные при РНС характеризуют преклиническую стадию инфекции, а при ПНС - ее клиническую стадию. В будущей ежедневной практике ПСП может быть ценным маркером для исключения РНС до начала антибиотикотерапии.

27.05.2019

Уровень пресепсина у новорожденных и детей первого года жизни с врожденными пороками сердца до и после хирургического лечения

Плющ М. Г., Подщеколдина О. О., Абрамян М. В., Ярустовский М. Б.

ФГБУ НЦССХ им. А.Н. Бакулева Минздрава России.

20.05.2019

Пресепсин в диагностике нозокомиальной инфекции центральной нервной системы

С.А. Абудеев1, К.В. Киселев2, О.В. Паринов1, Ю.Д. Удалов1, М.В. Забелин1, А.С. Самойлов1,
К.А. Попугаев1*
Отделение нейрореанимации и нейроанестезиологии
1 ФГБУ «ГНЦ — ФМБЦ имени А.И. Бурназяна» ФМБА,
Российская Федерация, 123098 Москва, ул. Маршала Новикова, д. 23
2 ГБОУ ВО «РНИМУ имени Н.И. Пирогова» Минздрава России,
Российская Федерация, 117997 Москва, ул. Островитянова, д. 1
* Контактная информация: Попугаев Константин Александрович, доктор медицинских наук, заведующий отделением нейрореанимации
ФГБУ ГНЦ ФМБЦ А.И. Бурназяна ФМБА России. E-mail: stan.popugaev@yahoo.com
20.05.2019

Пресепсин - маркер тяжести септическоо процесса у больных с некротическим панкреатитом

Гейгольник Д.В., Беляев К.Ю., Беляева И.П., Буйнов М.А., Васильев А.В., Морозова А.А, Шишканова О.В., Кох А.А., Черкасов А.А., Талыбов М.Н., Титова Н.М., Титова Н.М., Лысенко М.Н., Кузьменя В.И., Пушкарев Н.В., Янковский Р.В., Грицан А.И.

КГБУЗ Краевая клиническая больница г. Красноярск
13.05.2019

Биомаркеры при проведении интенсивной терапии сепсиса

А. А. Звягин, В. С. Демидова, Г. В. Смирнов
ФГБУ «НМИЦ хирургии им. А. В. Вишневского» Минздрава России
Россия, 119997, Москва, ул. Бол. Серпуховская, 27
06.05.2019

Сепсис-3. Реальный Прогресс?

Сепсис-3. Реальный Прогресс? Проценко Д.Н.
29.04.2019

A Patient of Using Presepsin to Diagnose Streptococcal Toxic Shock Syndrome during Anticancer Drug Treatment

Gaku Takahashi
Department of Critical Care, Disaster and GeneralMedicine, School of Medicine, Iwate Medical University, Japan
Correspondence should be addressed to Gaku Takahashi; gakut@iwate-med.ac.jp
Received 10 December 2018; Revised 18 March 2019; Accepted 2 April 2019; Published 16 April 2019
Academic Editor: Ricardo Jorge Dinis-Oliveira
15.04.2019

An evaluation of clinical inflammatory and coagulation markers in patients with sepsis: a pilot study

Emi Fujii, Kazunori Fujino, and Yutaka Eguchi
Department of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
15.04.2019

New Sepsis Marker-PRESEPSIN for early diagnosis and better prognosis of SEPSIS

18.03.2019

Значение пресепсина для прогнозирования краткосрочной динамики состояния и предотвращения избыточности антибактериальной терапии у пациентов с нозокомиальными инфекциями

К.А. Загородникова, Л.Б. Гайковая, А.Т. Бурбелло, М.А. Костицына,
М.В. Покладова, А.И. Ермаков, М.В. Комок
Северо-Западный государственный медицинский университет им. И.И.Мечникова, Санкт-Петербург, Россия
06.03.2019

Септическое острое повреждение почек: ранняя комплексная диагностика сепсиса и гломерулярной и тубулярной дисфункции

Вельков В.В., АО «ДИАКОН», 2018
06.03.2019

Сепсис и острое повреждение почек — дорога с двухсторонним движением: значения биомаркеров

Вельков В.В., АО «ДИАКОН», 2018
04.03.2019

The emerging role of Presepsin for diagnosis and monitoring of neonatal sepsis

Mitsubishi Chemical Europe GmbH
Willstätter Str. 30, 40549 Düsseldorf, Germany
Phone: +49 (0) 211 - 5 20 54 10
Facsimile: +49 (0) 211 - 59 12 72
email: Pathfast@mc-e.de
19.02.2019

Применение пресепсина в диагностике и мониторинге эффективности лечения сепсиса при ожоговой болезни

Евгений Жилинский,
врач-хирург ожогового отделения Городской клинической больницы скорой медицинской
помощи г. Минска, аспирант кафедры общей хирургии БГМУ
19.02.2019

Пресепсин – новый биомаркер сепсиса: Значение для педиатрии. Первые результаты отечественных исследований

В.В. Вельков
ЗАО «ДИАКОН», г. Пущино Московской области, РФ
19.02.2019

Пресепсин – эффективный биологический маркер для диагностики сепсиса и мониторинга системных инфекций

В.В. Вельков
Закрытое акционерное общество «Диакон», Московская область, г. Пущино.
12.02.2019

Первый опыт применения селективной лпс-адсорбции в комплексной интенсивной терапии детей с грамотрицательным сепсисом после кардиохирургических операций

Ярустовский М.Б., Абрамян М.В., Солдаткина А.О., Комардина Е.В.,
Назарова Е.И., Плющ М.Г., Рогальская Е.А.

ФГБУ «НМИЦ сердечно-сосудистой хирургии им. А.Н. Бакулева»
Минздрава России, 121552, Москва, Россия
02.02.2019

Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients

Elham A. Hassan 1,*, Abeer S. Abdel Rehim 1, Asmaa O. Ahmed 2, Hanan Abdullahtif 2 and
Alaa Attia 3 1 Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University,
Assiut 71111, Egypt; sharafabeer@yahoo.com 2 Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
asomar_12@yahoo.com (A.O.A.); Abdlatif@aun.edu.eg (H.A.) 3 Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
alaa.atya@med.au.edu.eg
* Correspondence: mam_elham75@yahoo.com; Tel.: +201002963415; Fax: +20882333327
23.01.2019

Can presepsin be used for screening invasive fungal infections?

Giuseppe Lippi 1 , Gianfranco Cervellin 2
1 Section of Clinical Biochemistry, University of Verona, Verona, Italy; 2 Emergency Department, University Hospital of Parma, Parma, Italy
Correspondence to: Prof. Giuseppe Lippi. Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy.
Email: giuseppe.lippi@univr.it
23.01.2019

Можно ли применять пресепсин для скрининга инвазивных грибковых инфекций?

Giuseppe Lippi, Gianfranco Cervellin. Can presepsin be used for screening invasive fungal infections?
Ann Transl Med. Accepted for publication Jan 16, 2019.
10.01.2019

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia

Igor Stoma1,2, Igor Karpov1, Anatoly Uss2, Svetlana Krivenko2, Igor Iskrov2, Natalia Milanovich2,
Svetlana Vlasenkova2, Irina Lendina2, Kristina Belyavskaya2, Veranika Charniak2
Correspondence: Igor Stoma (e-mail: igor.stoma@gmail.com).
09.01.2019

Presepsin: A promising biomarker for the detection of bacterial infections

Mohammad Yousef Memar, Hossein Bnnazadeh Baghi
Immunology Research Center, Tabriz, Iran
09.01.2019

Пресепсин – новый биологический маркер в диагностике и контроле эффективности лечения сепсиса

В. Г. Кукес 1, 2 , В. Ф. Маринин 1 , Ю. В. Олефир 2 , Е. В. Ших 1 , А. Б. Прокофьев 1, 2 ,
Д. О. Грапов 1 , Д. А. Вердиева 1 , Н. А. Румянцев 1, 2
1 Первый Московский государственный медицинский университет
им. И. М. Сеченова (Сеченовский Университет), Россия
2 Научный центр экспертизы средств медицинского применения, Москва, Россия
24.12.2018

Роль пресепсина в оценке тяжести и эффективности лечения гнойного пиелонефрита

Ю.Г. Чернова, А.И. Неймарк, А.П. Момот
1 ФГБОУ ВО АГМУ Минздрава РФ, Барнаул, Россия, 2 ФГБУ НМИЦ гематологии МЗ РФ, Барнаул, Россия
24.12.2018

The Physiological Variation in Plasma Presepsin Levels During the Early Neonatal Period

Masahiro Ishii, 1 Takayuki Hoshina, 1 Shun Ichikawa, 1 Daisuke Shimizu, 1
Shunsuke Araki, 1 Tadamune Kinjo, 1 Eiji Shibata, 2 Toru Hachisuga 2 and Koichi Kusuhara 1


1 Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Japan,
Kitakyushu, Fukuoka, Japan
2 Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental
Health, Japan, Kitakyushu, Fukuoka, Japan
10.12.2018

Роль современных маркеров системного воспаления в диагностике и прогнозировании течения инфекционного эндокардита

Л.А. БЕГАНСКАЯ1, А.П. РОЙТМАН1*, А.Г. МОРОЗОВ2, А.В. БУГРОВ1, Т.А. ФЕДОРОВА2, В.В. ДОЛГОВ1
1Кафедра клинической лабораторной диагностики Российской медицинской академии непрерывного последипломного
образования Российской Федерации, Москва, Россия; 2кафедра терапии ИПО Российской медицинской академии непрерывного
последипломного образования Российской Федерации, Москва, Россия
03.12.2018

Роль пресепсина в диагностике и оценке тяжести течения сепсиса и тяжелой пневмонии

Е.А. Титова 1, А.Р. Эйрих 2, З.А. Титова , Терапевтический архив . 2018; 11: 44-47
27.11.2018

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions

Naoki Watanabe 1* , Tomoya Ishii 1 , Nobuyuki Kita 1 , Nobuhiro Kanaji 1 , Hiroyuki Nakamura 2 , Nobuki Nanki 3 ,
Yutaka Ueda 4 , Yasunori Tojo 5 , Norimitsu Kadowaki 1 and Shuji Bandoh 1
27.11.2018

The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review

Lin Ruan 1* , Guan-Yu Chen 1 , Zhen Liu 1,2† , Yun Zhao 1,2† , Guang-Yu Xu 1,2† , Shu-Fang Li 1,2† , Chun-Ni Li 1,2† , Lin-Shan Chen 1,3† and Zheng Tao 1,3†
† Zhen Liu, Yun Zhao, Guang-Yu Xu, Shu-Fang Li, Chun-Ni Li, Lin-Shan Chen and Zheng Tao contributed equally to this work.
1 Departments of Anesthesiology, Guangxi Medical University Affiliated Tumor Hospital, Naning, Guangxi, China
Full list of author information is available at the end of the article
06.11.2018

Increased presepsin levels are associated with the severity of fungal bloodstream infections

Yuuki BambaID, Hiroshi MoroID*, Nobumasa Aoki, Takeshi Koizumi, Yasuyoshi Ohshima,
Satoshi WatanabeID, Takuro Sakagami, Toshiyuki Koya, Toshinori Takada,
Toshiaki Kikuchi
Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical
and Dental Sciences, Niigata, Japan.
22.10.2018

Алгоритм диагностики сепсиса у пациентов с ожоговой болезнью

УЗ "Городская клиническая больница скорой медицинской помощи" г. Минска
Врач-Хирург Ожогового Отделения Жилинский Е.В.
22.10.2018

Место пресепсина в скрининге инфекции у пациентов в критическом состоянии

ПСПБГМУ имени АК. И.П. Павлова Кафедра Анестизиологии и Реаниматологии
Ю.С. Полушин, И.В. Шлык, А.А. Афанасьев, Д.А. Малинина
09.10.2018

Значение пресепсина как раннего маркера гнойно-септических осложнений у пациентов с тяжелым панкреатитом

Н.Н. Салина*, В.П. Никулина, Р.Н. Борисов, М.А. Годков
Лаборатория клинической иммунологии, ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения
г. Москвы», Москва, Российская Федерация
14.09.2018

Место пресепсина в скрининге инфекции у пациентов в критическом состоянии

А. А. АФАНАСЬЕВ, Д. А. МАЛИНИНА, В. Н. КОЛЧАНОВА, И. В. ШЛЫК, Ю. С. ПОЛУШИН, Ю. П. КОВАЛЬЧУК
ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова», Санкт-Петербург,
Россия
20.06.2018

Биомаркеры инфекций в ОРИТ: новые возможности

Результаты  международных и отечественных клинических исследований.
К.б.н. Соловьева И.В.
Доцент кафедры КЛД МОНИКИ
им. М.Ф. Владимирского
Научно-практическая конференция «ИЗБРАННЫЕ ВОПРОСЫ АНЕСТЕЗИОЛОГИИ И РЕАНИМАТОЛОГИИ»
Тверь, 8 июня 2018
30.03.2018

Значение пресепсина как раннего маркёра гнойно-септических осложнений у пациентов с тяжёлым острым панкреатитом

"Неотложная медицинская помощь», 2018, 7(1).
Салина Н. Н., Никулина В.П., Борисов Р. Н., Годков М.А.
ГБУЗ НИИ СП им. Н.В.Склифосовского, Москва, Россия
30.03.2018

Пресепсин спинномозговой жидкости – маркер нозокомиальных инфекций ЦНС

Sergey A. Abudeev1, Kirill V. Kiselev2, Nikolay M. Kruglyakov1, Ksenia A. Belousova1, Inna
N. Lobanova1, Oleg V. Parinov1, Yuriy D. Udalov1, Maxim A. Zabelin1, Alexandr S.
Samoilov1, Evaldas Cesnulis3, Tim Killeen3 and Konstantin A. Popugaev1*
1 Burnazian State Research Center, Federal Medical-Biological Agency, Moscow, Russia, 2 Pirogov Russian National
Research Medical University, Russian Ministry of Education, Moscow, Russia, 3 Department of Neurosurgery, Klinik
Hirslanden, Zurich, Switzerland
25.03.2018

Пресепсин — новый диагностический маркер, позволяющий дифференцировать активный туберкулёз лёгких от бактериальной внебольничной пневмонии

Опубликовано: Пятница, 23 марта 2018 г. - 08:50
Тема: Инфекционные заболевания, клиника, диагностика и лечение
28.02.2018

Уровень пресепсина у новорожденных и детей первого года жизни с врожденными пороками сердца до и после хирургических вмешательств

М.Г. Плющ, О.О. Подщеколдина, М.В. Абрамян, М.Б. Ярустовский
ФГБУ "Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева"
26.02.2018

Диагностическая точность пресепсина при неонатальном сепсисе: мета-анализ

Ioannis Bellos, Georgia Firou, Vasilios Pergialiotis, Nikolaos Thomakos, Despina N. Perrea, Georgios Daskalatis

Springer-Verlag GmbH Germany, part of Springer Nature 2018

20.02.2018

Пресепсин – новый перспективный маркер генерализованных бактериальных и грибковых инфекциий

26.01.2018

Способ определения показаний к проведению селективной адсорбции эндотоксина у пациентов с сепсисом, вызванным грамотрицательными микроорганизмами

Автор(ы):
Рогальская Екатерина Анатольевна (RU), Климович Людмила Григорьевна (RU), Плющ Марина Георгиевна (RU), Самсонова Наталья Николаевна (RU), Ярустовский Михаил Борисович (RU), Абрамян Марина Владимировна (RU).
26.01.2018

Prognostic value of presepsin in adult patients with sepsis: Systematic review and metaanalysis

Hyun Suk Yang1, Mina Hur2*, Ahram Yi2, Hanah Kim2, Seungho Lee3, Soo-Nyung Kim4
1 Department of Cardiovascular Medicine, Research Institute of Medical Science, Konkuk University School
of Medicine, Seoul, Korea, 2 Department of Laboratory Medicine, Konkuk University School of Medicine,
Seoul, Korea, 3 School of Public Health, Seoul National University, Seoul, Korea, 4 Department of Obstetrics
and Gynecology, Konkuk University School of Medicine, Seoul, Korea
* dearmina@hanmail.net
14.12.2017

Stimulation of sCD14-ST (Presepsin) Secretion By Peripheral Blood Mononuclear Cells after Candida Albicans Lysate and Lipopolysaccharide Exposure

Aleksei Bazhenov, Gennadii M. Galstian, Maria Pashkova, Zoya Konova,
Mikhail Drokov and Valery Savchenko
08.12.2017

Presepsin: Early Biomarker in Diagnosis of Sepsis in Emergency Department

Ovidiu Popa1, Diana Cimpoieșu1* and Carmen Dorobăț2
1Emergency Department, St. “Spiridon” Hospital Iași, “Gr. T. Popa” University of Medicine and Pharmacy, Iași, Romania
2Department of Infectious Disease, Clinic Infectious Diseases Hospital Iași, “Gr. T. Popa” University of Medicine and Pharmacy, Iași, Romania
05.12.2017

Diagnostic Value of Presepsin in Sepsis

Silvana Teixeira Dal Ponte1*, Giordanna Andrioli 1, Luciano Passamani Diogo1, Renato Seligman2, Luciano Zubaran Goldani2, Andre Pinheiro Weber3, Gabriela Petitot Rezende4, Pauline Simas Machado4
1Emergency Physician, Emergency department, Hospital de Clinicas de Porto Alegre- Rs, Brazil
2Professor of Medicine, Universidade Federal do Rio Grande do Sul, Brazil
³Resident Emergency Medicine, Hospital de Pronto Socorro de Porto Alegre-RS, Brazil
4 Academic of Medicine, Universidade Federal do Rio Grande do Sul, Brazil
02.11.2017

Значение пресепсина как раннего маркёра гнойно-септических осложнений у пациентов с тяжёлым панкреатитом

Салина Н.Н., Годков М.А., Никулина В.П.,Александрова И.В., Борисов Р.Н.
ГБУЗ НИИ СП им. Н.В.Склифосовского, Москва, Россия
2017
19.10.2017

The role of presepsin, c-reactive protein and procalcitonin as a marker of therapy response and prognosis for late onset neonatal sepsis in preterm neonates

Dalima AW Astrawinata 1 , Risma Kerina Kaban 2 , Rosalina Dewi Roeslani 3 , Erna Parmawati 4
1 Department of Clinical Pathology, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
2 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
3 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
4 Department of Clinical Pathology Medical Specialty Program, Faculty of Medicine University Indonesia/Dr.Cipto
Mangunkusumo National General Hospital, Jakarta.
18.10.2017

Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication

Mohamed El-Saied El-Shafie a , Khaled M. Taema a, ⇑ , Moataz M. El-Hallag a ,
Abdallah Mohamed Abdallah Kandeel b
a, b
Critical Care Medicine, Cairo University, Egypt
Critical Care Medicine, El-Sahel Teaching Hospital, Egypt
18.10.2017

Диагностическое и прогностическое значение биохимических маркеров инфекционных осложнений высокодозной химиотерапии с аутологичной трансплантацией гемопоэтических стволовых клеток при злокачественных лимфопролиферативных заболеваниях

В.О. Саржевский, Ю.Н. Дубинина, В.Я. Мельниченко VO Sarzhevskii, YuN Dubinina, VYa Mel’nichenko
ФГБУ «Национальный медико-хирургический центр им. Н.И. Пиро-ова» Минздрава России, ул. Нижняя Первомайская, д. 70, Москва,
Российская Федерация, 105203
10.10.2017

Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis

В статье приводится таблица разлиных маркеров сепсиса, их чувствительность и специфичность.

Yong Liu 1† , Jun‐huan Hou 2,3† , Qing Li 2,3 , Kui‐jun Chen 2,3 , Shu‐Nan Wang 4 and Jian‐min Wang 2,3*
† Yong Liu and Jun-huan Hou contributed equally to this work
2 Research Institute of Surgery, Daping Hospital, Third Military Medical
University, Chongqing 400042, People’s Republic of China
Full list of author information is available at the end of the article
02.10.2017

Влияние искусственных дыхательных путей на исходы интенсивной терапии пожилых пациентов с острыми нарушениями мозгового кровообращения

КОХНО В.Н.1, КОМЗИН Д.В.2, РОГОВСКИХ В.Ю.2, ЛОКТИН Е.М.2, ШМАКОВ А.Н.1,
ФЛЯГИН Т.С.2 1 Новосибирский Государственный Медицинский Университет
2 МБУЗ НСО Городская Клиническая Больница № 2
ВЕСТНИК НОВЫХ МЕДИЦИНСКИХ ТЕХНОЛОГИЙ
Том: 24, Номер: 1 Год: 2017 Страницы: 103-108
УДК: 616.831-005-036.11-053.9:616-039.72
11.09.2017

Пресепсин – маркер сепсиса и тяжелой пневмонии

Титова Е.А., Реуцкая Е.М., Эйрих А.Р.
Пульмонология. 2017;27(3):366-370.
16.08.2017

Пресепсин: маркер динамики состояния у пациентов с ВБИ

Опубликовано на сайте www.zdrav.ru https://www.zdrav.ru/articles/4293657597-17-m6-19-presepsin-marker-dinamiki
14.08.2017

Новый высокочувствительный и высокоспецифичный маркер неонатального сепсиса - пресепсин

Д.Ж. БАТЫРБАЕВА, Б.А. РАМАЗАНОВА, А. БЕКНАЗАРОВА, Ж.С. АЛИБАЕВА, А.А. АБДРАИМОВА
А.Д. НУРАХОВА, Н.К. ИБРАЕВА, Р.С. БАТЫРХАНОВА
Казахский Национальный медицинский университет им. С.Д. Асфендиярова, НИИ ПФМ им. Б.А. Атшабарова,
Научная клинико-диагностическая лаборатория
14.08.2017

Прокальцитонин и пресепсин - клинические рекомендации по назначению и интерпретации результатов исследования

Лянг Ольга Викторовна
14.08.2017

Presepsin (sCD14-ST) Is a Novel Marker for Risk Stratification in Cardiac Surgery Patients

Hagen Bomberg, M.D., Matthias Klingele, M.D., Stefan Wagenpfeil, Ph.D., Eberhard Spanuth, Ph.D.,
Thomas Volk, M.D., Daniel I. Sessler, M.D., Hans-Joachim Schäfers, M.D.,
Heinrich Volker Groesdonk, M.D.
09.08.2017

Comparison of qSOFA (quick SOFA) Score, Presepsin, Procalcitonin and Lactate for Severity Assessment and Mortality Prediction in Patients with Initial Sepsis

E. Spanuth1, H. Ebelt2, B. Ivandic3, R. Thomae4, K. Werdan2. 1DIAneering - Diagnostics Engineering & Research,
Heidelberg, Germany, 2Department of Medicine III, University Clinics Halle (Saale), Martin-Luther- University Halle-Wittenberg,
Halle, Germany, 3Department of Medicine III, University of Heidelberg; DIAneering
– Diagnostics Engineering & Research, Heidelberg, Germany, 4Mitsubishi Chemical Europe, Düsseldorf, Germany
04.08.2017

Presepsin is a potent biomarker for diagnosing skin wound infection in hemodialysis patients compared to white blood cell count, high-sensitivity C-reactive protein, procalcitonin, and soluble CD14

Jun Shiota1,2*, Hitoshi Tagawa2, Norihiko Ohura3 and Hitoshi Kasahara2
* Correspondence: jun.siota@grp.zenjinkai.or.jp
1Department of Internal Medicine, Tsunashima Kidney Clinic, 1-10-4
Tsunashima-Higashi, Kohoku-ku, Yokohama 223-0052, Japan
2Department of Internal Medicine, Kichijoji Asahi Hospital, Tokyo, Japan
31.07.2017

Роль современных маркеров системного воспаления в диагностике и прогнозировании течения инфекционного эндокардита.

Л.А. Беганская, А.П. Ройтман, А.Г. Морозов, А.В. Бугров, Т.А. Федорова, В.В. Долгов.
Лабораторная служба. – 2017. – №2.
19.06.2017

Пресепсин – новый биомаркер сепсиса и тяжелых инфекций: ранняя диагностика, прогноз, мониторинг

Вельков В.В., АО «ДИАКОН», г. Пущино, Московская область, 142290
06.06.2017

Presepsin a diagnostic marker for sepsis in intensive care unit patients

Hanaa A Amer, Hala Ghareeb, Neama Lotfy, Noran O. El-Azizi, Sara Salem
Departments of Clinical Pathology and 2Internal Medicine & Rheumatology, Faculty
of Medicine, Ain Shams University, Cairo, Egypt
06.06.2017

Diagnostic Accuracy of Presepsin (sCD14-ST) for Prediction of Bacterial Infection in Cerebrospinal Fluid Samples from Children with Suspected Bacterial Meningitis or Ventriculitis

David Stubljar,a Andreja Natasa Kopitar,a Mojca Groselj-Grenc,b Kristina Suhadolc,c Teja Fabjan,c Miha Skvarca
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Sloveniaa; Department of Paediatric Surgery and Intensive Care,
University Medical Centre Ljubljana, Ljubljana, Sloveniab; Clinical Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Ljubljana, Sloveniac
02.06.2017

Comparison of lactate, presepsin and procalcitonin with the new Qsofa (quick sofa) score for severity assessment and mortality Prediction in patients with initial sepsis

E. Spanuth 3, H. Ebelt 1, B. Ivandic 2, R. Thomae 4, K. Werdan 1
1Department of Medicine III, University Clinics Halle (Saale), Martin-Luther-University Halle- Wittenberg, Germany
2Department of Medicine III, University of Heidelberg, Heidelberg, Germany; DIAneering – Diagnostics Engineering & Research
GmbH, Heidelberg, Germany
3DIAneering – Diagnostics Engineering & Research GmbH, Heidelberg, Germany
4Mitsubishi Chemical Europe, Düsseldorf, Germany
31.05.2017

Diagnostic Value of Presepsin in Neonatal Sepsis

Tabl HA, Abed NT.
Egypt J Immunol. 2016 Jun;23(2):29-37.
24.05.2017

Presepsin levels in cirrhotic patients with bacterial infections presented with or without acute kidney injury

Ioannis Elefsiniotis¹, Stefanos Α. Tsakiris¹, Georgia Barla¹, Eftychia Evangelidou¹, Dimitrios
Vrachatis¹, Christos Mavrogiannis¹ ¹Academic Department of Internal Medicine-­Hepatogastroenterology, General and Oncology
Hospital of Kifisia "Agioi Anargyroi", National and Kapodistrian University of Athens, Greece
23.05.2017

Поиск новых биомаркеров инфекционных обострений атопической бронхиальной астмы

Косякова Н.И., Прохоренко С.В., Андреева Л.А., Панкратова Е.В., Сахаров П.А.
Больница Научного Центра РАН, г.Пущино Федеральный научно-клинический центр реаниматологии и реабилитологии, Москва
16.05.2017

FRI-018 Presepsin (soluble CD14 subtype) levels in cirrhotic patients with bacterial infections and/or portal hypertension related bleeding presented with or without acute kidney injury

I.S. Elefsiniotis1 , S. Tsakiris1 , G. Barla1 , A. Tasovasili1 , I. Stathopoulou1 ,
K. Tampouratzi1 , E. , Evangelidou1 , D. Vrachatis1 , C. Mavrogiannis1 .
1 Internal Medicine-Hepatogastroenterology, General and Oncology Hospital of Kifisia “Agioi Anargyroi”,
National and Kapodistrian University of Athens, Athens, Greece E-mail: ielefs@nurs.uoa.gr
16.05.2017

Utility of presepsin and procalcitonin for infection diagnosis during Acute necrotizing pancreatitis

Igor Khomiak*2, Oleksandr Rotar1,2, Gregory Petrovsky3, Mikhail Nazarchuk3, Vasyl Rotar1, Andrii Khomiak2
1General Surgery, Bukovinian State Medical University, Chernivtsi, Ukraine; 2Department of Pancreas Surgery
and Bile Ducts Reconstruction Surgery, A. A.Shalimov National Institute of Surgery and Transplantology, Kyiv,
Ukraine; 35th City Hospital, Minsk, Belarus
16.05.2017

Использование биомаркёра «Пресепсин» для ранней и высокоспецифичной диагностики сепсиса

Руководства по клинической лабораторной диагностики.
Министерство Здравоохранения РФ.
Разработчик Вельков Василий Васильевич.
10.05.2017

The clinical significance of sCD14-ST for blood biomarker in neonatal hematosepsis

Ting Xiao, Master’s Degreea, Li-Ping Chen, Master’s Degreea, Li-hua Zhang, Bachelor’s Degreeb,
Fu-Huang Lai, Bachelor’s Degreeb, Li Zhang, Bachelor’s Degreeb, Qun-feng Qiu, Bachelor’s Degreea,
Rong-Liang Que, Bachelor’s Degreea, SiSi Xie, Master’s Degreea, Ding-Chang Wu, Bachelor’s Degreea,∗
10.05.2017

Неонатальный сепсис: гемокультуры и биомаркеры – Проблемы и перспективы

В.В. Вельков
АО «ДИАКОН», г. Пущино, Московская область, РФ
19.04.2017

The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis

Michael Yaroustovsky, Ekaterina Rogalskaya, Marina Plyushch,
Ludmila Klimovich, Nataliya Samsonova, and Marina Abramyan
Federal State Budget Institution “Bakulev National Scientific and Practical Center for Cardiovascular Surgery” of the Ministry of Healthcare of the Russian Federation (Bakulev NSPCCS), Moscow, Russia
19.04.2017

Диагностическое и прогностическое значение современных биохимических маркеров септических осложнений у больных после операций на сердце и сосудах

Рогальская Екатерина Анатольевна
АВТОРЕФЕРАТ
диссертации на соискание ученой степени кандидата медицинских наук
Москва – 2017
Диссертационная работа выполнена в Федеральном государственном бюджетном учреждении «Национальный научно-практический центр сердечно-сосудистой хирургии имени А.Н. Бакулева» Министерства здравоохранения Российской Федерации
Научные руководители:
Доктор медицинских наук, профессор, член-корр. РАН Ярустовский Михаил Борисович
Доктор медицинских наук, профессор Самсонова Наталия Николаевна
28.02.2017

Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication

Mohamed El-Saied El-Shafie a, Khaled M. Taema a,⇑, Moataz M. El-Hallag a,
Abdallah Mohamed Abdallah Kandeel b
a Critical Care Medicine, Cairo University, Egypt
b Critical Care Medicine, El-Sahel Teaching Hospital, Egypt
24.01.2017

Динамика прокальцитонина и пресепсина у пациентов с тяжелым сепсисом

Han Yu, Zhijiang Qi, Chenchen Hang, Yingying Fang, Rui Shao, Chunsheng Li.
The American Journal of Emergency Medicine, 2017, January
17.01.2017

Пресепсин: ранняя диагностика сепсиса и тяжелых инфекционных осложнений

Подготовлено врачом лаборатории клинической иммунологии
НИИ СП им. Н.В. Склифосовского ДЗ г. Москвы
Салиной Нелли Николаевной
09.01.2017

Биологические маркеры в диагностике и лечении сепсиса (обзор литературы)

А. А. Звягин, В. С. Демидова, Г. В. Смирнов
ФГБУ «Институт хирургии им. А. В. Вишневского» Минздрава России; Россия, 117997, Москва, ул. Большая Серпуховская, 27
Контакты: Альфред Аркадьевич Звягин zvyagin@ixv.ru
09.01.2017

Опыт использования пресепсина (sCD14-ST) для диагностики бактериальных инфекций у новорожденных

Е.М. КОЗЛОВА, Г.Л. ШУНЬКИНА, Н.М. ЧУМАК, П.П. БОЛЬШАКОВ, ГБУЗ НО «Детская городская клиническая больница № 1
Приокского района г. Нижнего Новгорода»
09.01.2017

Мониторинг уровня scd14-st (пресепсина) в периоперационном периоде у кардиохирургических больных

Д. А. Попов, М. Г. Плющ, С. Т. Овсеенко, М. В. Абрамян, О. О. Подщеколдина, М. Б. Ярустовский
ФГБУ НЦ ССХ им. А. Н. Бакулева РАМН, 111552, Москва
09.01.2017

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients

Yusuke Koizumi1,2*, Kaoru Shimizu3, Masayo Shigeta3, Takafumi Okuno2, Hitoshi Minamiguchi2, Katsuyuki Kito2,
Keiko Hodohara2, Yuka Yamagishi1, Akira Andoh2, Yoshihide Fujiyama2 and Hiroshige Mikamo1
1Department of Clinical Infectious Diseases, Aichi Medical University, 1-1
Yazakokarimata, Nagakute, Aichi 480-1195, Japan
2Department of Gastroenterology and Hematology, Shiga University of Medical Science, Otsu 520-2192, Japan
09.01.2017

Оценка прогностической значимости маркеров воспаления у детей с онкопатологией

Е.Г. Головня, А.В. Сотников, В.Н. Байкова, А.В. Лебедева
Российский онкологический научный центр им. Н.Н. Блохина Минздрава России,
Москва, Российская Федерация
27.12.2016

Presepsin and Inflammatory Markers Correlate with Non-occlusive Mesenteric Ischemia after Cardiovascular Surgery

Jonas Stroeder, MD, Homburg, Germany (Presenter) Nothing to Disclose
Heinrich Groesdonk, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Hans-Joachim Schaefers, MD, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Matthias Klingele, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Stefan Wagenpfeil, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Marcus Katoh, MD, Krefeld, Germany (Abstract Co-Author) Consultant, Straub Medical AG Consultant, Medtronic, Inc
Hagen Bomberg, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Arno Buecker, MD, Homburg, Germany (Abstract Co-Author) Research Grant, Siemens AG; Consultant, Bracco Group; Speaker,
Peter Minko, MD, Homburg, Germany (Abstract Co-Author) Speaker, Straub Medical AG Consultant,
Straub Medical AG
26.12.2016

Diagnostic and Prognostic Value of Presepsin for Subclinical Chorioamnionitis in Pregnancies between 23-28 Week with Preterm Premature Rupture of the Membranes

Erbil Çakar¹, Şule Eren Çakar², Habibe Ayvacı Taşan¹, Deniz Karçaaltıncaba³, Mehmet Baki Şentürk¹,
Nermin Koç4, Ramazan Uluhan5

¹Department of Obstetrics and Gynecology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
²Deparment of Infectious Diseases, Ümraniye Training and Research Hospital, İstanbul, Turkey
³Department of Obstetrics and Gynecology, Gazi University School of Medicine, Ankara, Turkey
4Department of Pathology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
5Department of Clinical Microbiology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
26.12.2016

Biomarkers of Sepsis

26.12.2016

Prognostic value of sCD14-ST (presepsin) in cardiac surgery

Dmitry Popov, Marina Plyushch, Svetlana Ovseenko, Marina Abramyan, Olga Podshchekoldina,
Mikhail Yaroustovsky
Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russian Federation
26.12.2016

The Results of the Russian Clinical Trial of Mesenchymal Stromal Cells (MSCs) in Severe Neutropenic Patients (pts) with Septic Shock (SS) (RUMCESS trial)

Gennadii M. Galstian, Elena N. Parovichnikova, Polina M. Makarova, Larisa A. Kuzmina,
Vera V. Troitskaya, Eduard Gemdzhian, Nina I. Drize and Valeri G. Savchenko
Blood 2015 126:2220; http://www.bloodjournal.org/content/126/23/2220?sso-checked=true
22.12.2016

Soluble CD14 subtype (SCD14-ST) presepsin levels in preterm newborns with RDS

N. Kultursay1 , S.Ergör 1, O. Altun Koroglu 1, M. Yalaz 1, M. Akisu 1
Division of Neonatology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey
07.12.2016

Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis

Maria Papp, Tamas Tornai, Zsuzsanna Vitalis, Istvan Tornai, David Tornai, Tamas Dinya, Andrea Sumegi,
Peter Antal-Szalmas
05.12.2016

Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections

Tatsuo Oyake, Takayuki Masuda, Norifumi Sugawara, Maki Asahi, Yuzo Suzuki, Yoshi
aki Okano, Yukiteru Fujishima, Yusei Aoki, Shugo Kowata, Shigeki Ito and YojiIshida
02.12.2016

Пресепсин и метаболиты оксида азота при инфекционных осложнениях у детей с онкопатологией

Е.Г. Головня1, А.В. Сотников1, В.Н. Байкова1, О.П. Петина1
1 Российский онкологический научный центр им. Н.Н. Блохина, Москва, Российская Федерация
02.12.2016

Presepsin in Early Laboratory Diagnostics and Monitoring of Sepsis in Pediatric Patients with Oncology Diseases

Golovnya E., Baykova V., Saltanov A., Sotnikov A.
Institute of Pediatric Oncology and Hematology of Federal State N. N. Blokhin Russian Cancer Research Center, Moscow
3rd international Presepsin workshop,
Rome, September 17, 2016
30.11.2016

Presepsin a new marker for critical care? Clinical studies & outcomes

Dr. Ralf Thomae
General Manager & Representative Diagnostic Business
Mitsubishi Chemical Europe GmbH
03.11.2016

Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies

Satoru Nanno1, Hideo Koh1, Takako Katayama 1, Masamichi Hashiba 2, Ayumi Sato 2,
Yosuke Makuuchi1, Joji Nagasaki 1, Masatomo Kuno1, Takuro Yoshimura 1, Hiroshi Okamura1,
Mitsutaka Nishimoto 1, Asao Hirose 1, Mika Nakamae1, Takahiko Nakane 1,
Masayuki Hino1 and Hirohisa Nakamae1
02.11.2016

Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens

Igor Stoma a,* , Igor Karpov a , Anatoly Uss b , Oleg Rummo b ,
Natalia Milanovich b , Igor Iskrov b
a Department of Infectious Diseases, Belarusian State Medical University, Minsk, Belarus
b City Clinical Hospital No. 9, Minsk, Belarus
29.09.2016

Пресепсин – маркер сепсиса

Кутепов Д.Б., д.м.н., врач-анестезиолог-реаниматолог,
зав. отд. экстракорпоральных методов лечения.
ФГБУ "Клиническая больница №1" Управления делами Президента РФ
(Волынская), Москва
14.09.2016

Прeсепсин пригоден для ранней диагностики сепсиса согласно новому международному определению СЕПСИС-3

EuSEM congress,Vienna, 2-5 October, 2016.Abstracts
Tomonori YAMAMOTO, Yamamoto HIROMASA, Tetsuro Nishimura TETSURO,
Shinyama NAOKI, Noda TOMOHIRO, Shinichiro KAGA, Takahumi TERADA,
Kenichiro UCHIDA, Takasei MORIOKA, Hiroharu TAKESADA, Maiko ESAKI, Hoshi
HIMURA, Yasumitsu MIZOBATA
07.09.2016

Пресепсин – ранний и надежный диагностический и прогностический маркер неонатального сепсиса

Jehan H Sabry1, Osama A Elfeky2, Akram E Elsadek3, Ahmed A Eldaly4.
1. Assistant Professor of Clinical & Chemical Pathology, Benha Faculty of Medicine, Egypt.
2. Professor of Pediatrics, Benha Faculty of Medicine, Egypt.
3. Lecturer of Pediatric, Benha Faculty of Medicine, Egypt.
4. Resident of Pediatrics, Ministry of Health, Egypt.
23.08.2016

Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies

Satoru Nanno1, Hideo Koh1, Takako Katayama 1, Masamichi Hashiba 2, Ayumi Sato 2,
Yosuke Makuuchi1, Joji Nagasaki 1, Masatomo Kuno1, Takuro Yoshimura 1, Hiroshi Okamura1,
Mitsutaka Nishimoto 1, Asao Hirose 1, Mika Nakamae1, Takahiko Nakane 1,
Masayuki Hino1 and Hirohisa Nakamae1
17.08.2016

sCD14-ST in the early diagnosis of sepsis

LIAO Juan, LIN Lixing, LI Yangyu, QIN Xuejun, ZHOU Zixin, CHEN Rongyan,
SONG Yanfang, LIN Qing
Department of Clinical Laboratory,the People's Hospital Affiliated to Fujian University of
Traditional Chinese Medicine,Fuzhou 350004, Fujian,China
17.08.2016

Presepsin acurately predicts mortality in patients undergoing transcatheter aortic valve implantation (TAVI)

Silvana Hamati, Mirko Doss, Thomas Walther, Christoph Liebetrau
Department of Cardiovascular Surgery
Kerckhoff-Klinik Bad Nauheim
Germany
16.08.2016

Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury

Takahashi G, Shibata S, Fukui Y, Okamura Y, Inoue Y,
Diagnostic Microbiology and Infectious Disease, 12 July 2016
19.07.2016

Пресепсин как маркер краткосрочной динамики состояния у пациентов с внутрибольничной инфекцией

Справочник заведующего КДЛ, 2016, N7

Л.Б. Гайковая, д-р мед. наук, заведующая центральной клинико-диагностической лабораторией, заведующая кафедрой биологической и общей химии,
К.А. Загородникова, канд. мед. наук, доцент кафедры терапии и клинической фармакологии
А.И. Ермаков, врач клинической лабораторной диагностики центральной клинико-диагностической лаборатории
А.С. Федоренко, канд. мед. наук, врач – клинический фармаколог
М.А. Костицына, врач – клинический фармаколог
М.В. Покладова, врач – клинический фармаколог
А.Т. Бурбелло, д-р мед. наук, проф., врач – клинический фармаколог
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России, г. Санкт-Петербург
13.07.2016

Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis

Ali FT, Ali MAM, Elnakeeb MM, Bendary HNM.
Clinica Chimica Acta 460 (2016) 93–101
12.07.2016

The role of Presepsin (sCD14-ST) as an indirect marker of microbial translocation and immune activation in HIV and HIV/HCV coinfected patients

V. Zuccaro (1), P. Sacchi (1), S. Cima (1), P. Columpsi (1), S. Toppino (1), S. Paolucci (2), G. Comolli (2), F. Baldanti (2), M. Mariconti (1), R. Bruno (1)
1) Dipartimento di Malattie Infettive, Fondazione IRCCS Policlinico San Matteo, Pavia .
2) Unità di Virologia Molecolare, S.C. di Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia
12.07.2016

Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community‑acquired pneumonia in ICU patients

Kada Klouche1,2* , Jean Paul Cristol2,3, Julie Devin3, Vincent Gilles1, Nils Kuster3, Romaric Larcher1,
Laurent Amigues1, Philippe Corne1, Olivier Jonquet1 and Anne Marie Dupuy3
01.07.2016

Presepsin as an important diagnostic biomarker that differentiates sepsis from non-infectious SIRS in critical ill adult patients: A system review and meta-analysis

Dan Xie1 †, Kunpeng Hu2 †, Purun Lei3, Ying Xian1, Ying Wang1, Xiaogang Bi1, Kouxing Zhang1*
*Correspondence: Professor Kouxing Zhang, Department of General ICU of Lingnan Hospital, The Third Affiliated Hospital, Sun Yat-sen
University, Guangzhou, China,
01.07.2016

Применение пресепсина и прокальцитонина в диагностике сепсиса у тяжело обожженных пациентов

Жилинский Е.В.1, Алексеев С.А. 2, Жензерова И.А. 1, Блыга Е.Г. 1
УЗ «Городская клиническая больница скорой медицинской помощи», Минск, Беларусь
УО «Белорусский государственный медицинский университет», Минск, Беларусь
27.06.2016

PATHFAST Presepsin in Patients with SIRS and Early Sepsis in the Emergency Department

Ricardo Carpio1, Eberhard Spanuth2
1)Hospital Nacional Edgardo Rebagliati Martins-EsSalud, Lima, Peru
2)DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
15.06.2016

Application of presepsin in diagnosis and treatment of purulent-septic complications of acute necrotic pancreatitis

Klin Khir. 2016 Jan;(1):20-2. Article in Ukrainian. Rotar OV.
18.05.2016

Биомаркеры неонатального сепсиса: С-реактивный белок, прокальцитонин, пресепсин

В.В. Вельков, к. б. н., директор по науке
АО «ДИАКОН», г. Пущино, Московская область
Biomarkers of neonatal sepsis: C-reactive protein, procalcitonin, presepsin
V. V. Velkov
DIAKON Co., Pushchino, Moscow region, Russia
13.04.2016

Role of Presepsin for the Assessment of Acute Cholangitis Severity

Jianbo Lin1, Huidong Sun2, Jiangong Li1, Yanhong Zheng1, Cunhua Shao1, Yang Zhang1, Hong Chang3
1 Department of Hepatobiliary Surgery, Shandong Provincial Hospital (group) Dongying Hospital Affiliated to Shandong University, Dongying
People’s Hospital, Dongying, Shandong, China 2 Department of Hepatobiliary Surgery, The People's Hospital of Liaocheng, Liaocheng,
Shandong, China 3 Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
13.04.2016

ПРЕСЕПСИН. Краткая информация.

Чем раньше диагностирован сепсис, тем раньше назначается эффективная терапия - тем выше выживаемость пациентов.
Проблемы, связанные с традиционными маркерами сепсиса.
28.03.2016

Presepsin levels of patients with Crimean-Congo hemorrhagic fever

Advance Publication by J-STAGE
Japanese Journal of Infectious Diseases
04.02.2016

Novel Predictor Of Mortality In Patients Undergoing Transcatheter Aortic Valve Implantation

Silvana Hamati, Mirko Doss, Christoph Liebetrau, Thomas Walther.
Kerckhoff Heart Center Bad Nauheim, Bad Nauheim, Germany.
13.01.2016

Использование пресепсина (sCD14-ST) в качестве маркера сепсиса при критических состояниях

Е.Г. Головня, А.И. Салтанов, А.В. Сотников, В.Н. Байкова
Научно-исследовательский институт детской онкологии и гематологии Российского онкологического
научного центра им. Н.Н. Блохина Минздрава России, Москва, Российская Федерация
11.01.2016

Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates

Lorenza Pugni1*, Carlo Pietrasanta1, Silvano Milani2, Claudia Vener2, Andrea Ronchi1,
Mariella Falbo1, Milena Arghittu3, Fabio Mosca1
1 NICU, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico, University of Milan, Milan, Italy, 2 Laboratory “GA Maccacaro”, Department of Clinical
Sciences and Community Health, University of Milan, Milan, Italy, 3 Microbiology Laboratory, Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
11.01.2016

Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line

Chenevier-Gobeaux C, Bardet V, Poupet H, Poyart C, Borderie D, Claessens YE.
11.01.2016

Biomarkers and empiric antibiotic therapy appropriateness in critically ill septic patients: role of presepsin

R. Renna, S. Cassano, A. Sicolo, G. Lupo, M.J. Mura Ondok, G. Altamura,
L. Dalfino, F. Bruno, N. Brienza
Anesthesia and Intensive Care Unit, Department of Emergency and Organ
Transplantation, University Aldo Moro of Bari, Bari, Italy
11.01.2016

Presepsin and procalcitonin for sepsis diagnosis and appropriateness of antibiotic therapy prediction in critically ill patients

F. Di Serio1, L. Varraso1, L. Dalfino2, S. Cassano2, R.G. Renna2, F. Bruno2
1Clinical Pathologist Unit, University-Hospital Bari, Bari
2Anesthesia and Intensive Care Unit, University-Hospital Bari, Bari
24.12.2015

Роль маркеров в оценке эффективности действия лекарственных средств при воспалительных заболеваниях

Кукес В.Г., Липатов К.В., Маринин В.Ф.
ФГБУ «НЦЭСМП» Минздрава России г. Москва
ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России г. Москва
24.12.2015

Использование Пресепсина как раннего маркера инфекции у онкологических больных детского возраста

Е.Г. Головня, В.Н. Байкова, А.И. Салтанов, А.В. Сотников
Российский онкологический научный центр им. Н.Н. Блохина Минздрава России,
Москва, Российская Федерация
15.10.2015

Presepsin as a new biomarker for old expectations in the diagnosis and prognosis of bacterial infection in cirrhosis

Maria Papp*, Tamas Tornai1, David Tornai2, Zsuzsanna Vitalis1, Istvan Tornai1,
Peter Antal-Szalmas2
1Gastroenterology, 2Laboratory Medicine, University of Debrecen, Debrecen, Hungary
Corresponding author’s e-mail: drpappm@yahoo.com
15.10.2015

Soluble CD14-subtype (Prespsin) and Hepcidin as Diagnostic and Prognostic markers in Early Onset Neonatal Sepsis

1Tawfik Abdel Motalib*, 2Fatma A Khalaf , 3Ghada El Hendawy,
4Sobhy E Kotb, 5Aml M Ali, 6Amal El Sharnoby
Departments of 1Microbiology, 2Clinical Biochemistry & 6Clinical Pathology, National Liver Institute, Menoufiya
University; 3Microbiology Department, Faculty of Medicine - Menoufiya University; Departments of Pediatric,
4Dubai Hospital & 5Ahmed Maher Teaching Hospital
14.10.2015

Новая технология селективной гемосорбции у больных с септическим шоком

А.Ю. Яковлев, А.В. Абрамов, Ю.Д. Бричкин, А.Ю. Сморкалов, Ф.Ф. Бершадский,
ГБУЗ НО «Нижегородская областная клиническая больница им. Н.А. Семашко»
08.10.2015

Presepsin Summary by Corrado Moiraghi

Marco Ulla Elisa Pizzolato Manuela Lucchiari
Maria Loiacono Flavia Soardo Daniela Forno
Fulvio Morello Enrico Lupia Corrado Moiraghi Giulio Mengozzi Stefania Battista
Corrado Moiraghi http://science.report/author/corrado-moiraghi/
07.10.2015

Применение мультипотентных мезенхимных стромальных клеток для лечения септического шока у больных в состоянии агранулоцитоза.

Макарова Полина Михайловна
Федеральное государственное бюджетное учреждение
Гематологический научный центр
Министерства здравоохранения Российской Федерации
На правах рукописи
07.10.2015

Сравнительный анализ диагностической значимости пресепсина с-реактивного белка и прокальцитонина

Полякова И.Н.
НИИ скорой помощи им. Н.В. Склифосовского
Москва, 2014
06.10.2015

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment

Michael Behnes1, Thomas Bertsch2, Dominic Lepiorz1, Siegfried Lang1, Frederik Trinkmann1, Martina Brueckmann3,
Martin Borggrefe1 and Ursula Hoffmann1*
05.10.2015

Validation of the New Biomarker Presepsin for Diagnosis of Sepsis

Ryu Azumaguchi, M.D., Shota  Satoh, M.D., Natsumi Kii,
M.D., Hiroomi Tatsumi, M.D.,Ph.D., Yoshiki Masuda,
M.D.,Ph.D., Michiaki Yamakage, M.D.,Ph.D.
Sapporo Medical University, Sapporo, Japan
05.10.2015

The False Positive Soluble CD 14 Subtype is Lower Than That of Procalcitonin in Postoperative Severe Elective Surgery Patients: A Prospective Observational Trial

Yoshitaka Hara, M.D., Tomoyuki Nakamura, M.D., Naohide Kuriyama, M.D.,
Satoshi Komatsu, M.D., Seiko Hayakawa, M.D., Sohta Uchiyama, M.D.,
Daisuke Niimi, M.D., Chizuru Yamashita, M.D., Junpei Shibata, M.D.,
Ph.D., Osamu Nishida, M.D.,Ph.D.
Fujita Health University School of Medicine, Toyoake, Japan
05.10.2015

Evidence That Presepsin is an Early Marker of Postoperative Infection After Cardiac Surgery

Hiroto Suzuki, M.D., Midori Watanabe, M.D., Naohisa Nakamura,
M.D., Yuu Matsuura, M.D., Yuu Onodera, M.D., Masaki Nakane,
M.D., Kaneyuki Kawamae, M.D.
Yamagata University Hospital, Yamagata-shi, Japan
02.09.2015

Вазоактивный эффект ропивокаина при блокаде седалищного нерва у больных с диабетической стопой

Т. С. Флягин1, В. Н. Кохно2, Е. М. Локтин1
1ГБУЗ НСО «Городская клиническая больница № 2» (г. Новосибирск)
2ГБОУ ВПО «Новосибирский государственный медицинский университет» Минздрава
России (г. Новосибирск)
02.09.2015

Комплекс лабораторных маркеров ранней диагностики системной воспалительной реакции и сепсиса

В.П. Никулина, М.В. Андросова, Т.В. Черненькая,
А.И. Баженов, М.А. Годков
НИИ скорой помощи им. Н.В. Склифосовского ДЗ г. Москвы
02.09.2015

Динамика пресепсина и прокальцитонина у пациентов хирургического профиля

Кулабухов В.В., Демидова В.С., Кудрявцев А.Н., Чижов А.Г., Звягин А.А.,
Терехова Р.П., Баранова А.А.
ФГБУ «Институт хирургии им. А.В.Вишневского» Минздрава России
Тезисы XII Съезда хирургов России 5-10 октября 2015 г. г. Ростов-на-Дону
02.09.2015

Пресепсин в алгоритме лабораторной диагностики хирургической инфекции у пациентов в критическом состоянии

Демидова В.С., Ушакова Т.А., Звягин А.А.,
Бобровников А.Э., Крутиков М.Г., Медова О.В.,
Кучейник А.Ш., Коряков И.А.
ФГБУ «Институт хирургии им. А.В. Вишневского»,
г. Москва, Россия
13.08.2015

Пресепсин – эффективный маркер гнойно-септических осложнений острого панкреатита.

Смирнов Г.В., Красносельский М.Я., Фролков В.В. и сотр.
Эфферентная терапия, 2014,20,1,30
ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
13.08.2015

Определение пресепсина и других маркеров эндотоксикоза в диагностике сепсиса при панкреатитах.

Токарева Е.В., Фурман О.Л., Прогрессов А.Ю., Савченко Р.П., Прокаева П.А.
ГБУЗ «Пензенская областная клиническая больница им. Н. Н. Бурденко»,
г. Пенза, Россия
28.07.2015

Usefulness of Presepsin (sCD14-ST) in diagnosis of Infective Endocarditis - preliminary results of an observational study

Adriana Topan1, Dumitru Carstina1, Raluca Rancea2, Adriana Slavovici1, Mirela
Flonta3, Mihaela Lupse1
1. University of Medicine and Pharmacy”Iuliu Hatieganu”, Cluj-Napoca; 2. Institut of the Heart
“Nicolae Stancioiu” , Cluj – Napoca; 3. Hospital of Infectious Diseases, Cluj- Napoca, Romania
24.07.2015

Клиническая значимость пресепсина при инфекционных осложнениях у хирургических больных и пациентов с ожоговой травмой

В.С.Демидова, Т.А.Ушакова, А.А.Звягин, А.Э.Бобровников, О.В.Медова, И.А.Коряков
ФГБУ Институт хирургии им. А.В.Вишневского Минздрава России, Москва
ИНФЕКЦИИ В ХИРУРГИИ | № 4 | 2014
23.07.2015

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients

T Ikeda, S Ono, T Ueno, H Tanaka, S Suda<br>Hachiouji Medical Center, Tokyo Medical University, Tokyo, Japan Critical Care 2015, 19(Suppl 1):P62 (doi: 10.1186/cc14142)<br>
23.07.2015

Использование биомаркера пресепсин для ранней и высокоспецифичной диагностики сепсиса

«Раны и раневые инфекции», Журнал им. проф. Б.М. Костючёнка
22.07.2015

Prognostic value of PSP in predicting adverse renal outcomes and death cardiosurgical patients

Alessandra Brocca
San-Bortolo Hospital, Italy
30.06.2015

Monitoring of weaning from mechanical ventilation in Critical ill patients by pathfast presepsin at the intensive care unit

E. Spanuth 2, R. Thomae 3, E. Giannitsis 1
1Deptartment of Medicine III, Div. of Cardiology, University of Heidelberg, Heidelberg, Germany
2DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
3Misubishi Chemical Europe, Düsseldorf, Germany
30.06.2015

Presepsin can replace procalcitonin in the prediction of sepsis In transplant patients after antithymocyte globulin administration

E. Spanuth1, B. Ivandic1, J. Wilhelm3, R. Thomae2, K. Werdan3
1DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
2Mitsubishi Chemical Europe, Düsseldorf, Germany
3University Clinics Halle (Saale), Department of Medicine III, Martin-Luther-University
Halle-Wittenberg, Germany
15.06.2015

Биохимические маркеры в диагностике сепсиса у пациентов детского возраста: опыт применения пресепсина

Н.Я. Бовтюк, И.В. Пудакевич, Н.А. Филон
Белорусский государственный медицинский университет, Минск, Беларусь
15.06.2015

Prognostic significance of presepsin in patients with sepsis

E. Rogalskaya3, M. Plyushsh2, N. Samsonova3, M. Yaroustovsky1
1Department of Detoxication and Endoscopy, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
2Laboratory of Biochemistry, Clinical Laboratory Diagnostics Division, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
3Laboratory of Hematology, Clinical Laboratory Diagnostics Division, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
03.06.2015

Clinical Impact of Kidney Function on Presepsin Levels

Takanobu Nagata1, Yoshinari Yasuda1, Masahiko Ando2, Tomoko Abe1,
Takayuki Katsuno1, Sawako Kato1, Naotake Tsuboi1, Seiichi Matsuo1,
Shoichi Maruyama1*
1 Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2 Center for
Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
03.06.2015

Combined assessment of presepsin (scd14-st) and mortality in Emergency department sepsis (meds) score improves outcome prediction of sepsis

E. Spanuth1, B. Ivandic1, J. Wilhelm3, R. Thomae2, K. Werdan3
1DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
2Mitsubishi Chemical Europe, Düsseldorf, Germany
3University Clinics Halle (Saale), Department of Medicine III, Martin-Luther-University
Halle-Wittenberg, Germany
01.06.2015

Фагоцитоз, осуществляемый моноцитами человека, необходим для секреции пресепсина

Arai Y, Mizugishi K, Nonomura K , Naitoh K, Takaori-Kondo A.
01.06.2015

Механизм образования пресепсина: новые данные

АО «ДИАКОН», 2015
30.04.2015

Перспективы применения новых лабораторных методов в ранней диагностике сепсиса

Годило-Годлевский В.А., полковник вн. сл. в отставке, заместитель главного врача Медико-реабилитационного центра «Здоровье для вас», доцент кафедры факультативной терапии и пропедевтики внутренних болезней Государственной классической академии им. Маймонида, д.м.н., vg-god@rambler.ru
Гурбатова Т.Ю., начальник лабораторного отделения Главного клинического госпиталя МВД России;
Мельникова С.В., подполковник вн. сл., заместитель начальника лабораторного отделения – врач клинической лабораторной диагностики Главного клинического госпиталя МВД России, к.б.н.
22.04.2015

Пресепсин в диагностике гнойных осложнений у хирургических больных и пациентов с ожоговой травмой

Демидова В.С., Ушакова Т.А., Звягин А.А., Бобровников А.Э., Медова О.В., Коряков
И.А., Казеннов В. В., Шишкин М.Н., Баранова А.А., Самадурова Л.Л., Кучейник А.Ш.
ФГБУ «Институт хирургии им. А.В. Вишневского», Россия, Москва
22.04.2015

Маркеры воспаления в диагностике ожогового сепсиса

Ушакова Т.А., Алексеев А.А., Крутиков М.Г., Бобровников А.Э.
ФГБУ «Институт хирургии им. А.В. Вишневского» МЗ России, г. Москва
Кафедра термических поражений, ран и раневых инфекций ГБОУ ДПО РМАПО
г. Москва
22.04.2015

Значение определения пресепсина в диагностике сепсиса у пациентов c тяжелой термической травмой

Н.А. Гординская, М.Ю. Лебедев, М.В. Преснякова,
ФГБУ «Нижегородский научно-исследовательский институт травматологии и ортопедии»
20.04.2015

Role of presepsin for the evaluation of sepsis in the emergency department

Elisa Pizzolato*, Marco Ulla, Claudia Galluzzo, Manuela Lucchiari, Tilde Manetta,
Enrico Lupia, Giulio Mengozzi and Stefania Battista
14.04.2015

Diagnostic Value of Presepsin (Scd14-St Subtype) Evaluation in the Detection of Severe Neonatal Infections

Stojewska Małgorzata Department of Pediatrics Zabrze, Silesian Medical University Katowice, Poland
Behrendt Jakub, Szymańska Anna, Pukas-Bochenek Anna, Stachurska Aneta, Godula – Stuglik Urszula Department of Neonatal Intensive Care Units Zabrze, Silesian Medical University Katowice, Poland
Mazur Bogdan Depatrment of Microbiology and Immunology Zabrze, Silesian Medical University Katowice, Poland
14.04.2015

Маркеры воспаления в диагностике ожогового сепсиса

Ушакова Т.А., Алексеев А.А., Крутиков М.Г., Бобровников А.Э.
ФГБУ «Институт хирургии им. А.В. Вишневского» МЗ России, г. Москва
Кафедра термических поражений, ран и раневых инфекций ГБОУ ДПО РМАПО
14.04.2015

Presepsin: A Novel and Potential Diagnostic Biomarker for Sepsis

K V Ramana1,*, Venkata BharatKumar Pinnelli2, Sabitha Kandi3, Asha G2, Jayashankar CA4, Bhanuprakash5, Raghavendra DS2, Sanjeev D rao1
1Department of Microbiology, Prathima Institute of Medical sciences, Karimnagar, India 2Department of Biochemistry, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 3Department of Biochemistry, Chalmeda Anandarao Institute of Medical sciences, Karimnagar, India 4Department of General Medicine, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 5Department of Dermatology, Vydehi Institute of Medical sciences and Research center, Bengaluru, India
*Corresponding author: ramana_20021@rediffmail.com
14.04.2015

Diagnostic and prognostic value of presepsin in the emergency department

T.O. Popa, Diana Cimpoesu, Carmen Michaela Dorobat
University of Medicine and Pharmacy "Grigore T.Popa" - Iasi
14.04.2015

PATHFAST Presepsin assay for early diagnosis of bacterial infections in surgical patients. Preliminary study.

G. Novelli; V. Morabito; G. Ferretti; F. Pugliese; F. Ruberto; M. Rossi; P.B. Berloco
Department of General Surgery and Organ Transplant; Sapienza University of Rome
14.04.2015

Early diagnosis of bacterial infections in surgical patients. Use of pathfast presepsin assay

V. Morabito
University La Sapienza, Italy
14.04.2015

Значение пресепсина как нового Биомаркера инфекции при ургентной Хирургической патологии

Полякова И.Н.
НИИ скорой помощи им. Н.В. Склифосовского
Москва 2014
14.04.2015

Prognostic value of sCD14-ST (presepsin) in cardiac surgery

Dmitry Popov, Marina Plyushch, Svetlana Ovseenko, Marina Abramyan, Olga Podshchekoldina, Mikhail Yaroustovsky
Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russian Federation
08.04.2015

Diagnostic and prognostic performance of PATHFAST Presepsin in patients with SIRS and early sepsis

E Spanuth1, R Carpio2, R Thomae3
1DIAneering GmbH, Heidelberg, Germany; 2Hospital Nacional Edgardo
Rebagliati Martins-EsSalud, Lima, Peru; 3Mitsubishi Chemical Europe,
Dьsseldorf, Germany
Critical Care 2015, 19(Suppl 1):P63 (doi: 10.1186/cc14143)
08.04.2015

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients

T Ikeda, S Ono, T Ueno, H Tanaka, S Suda
Hachiouji Medical Center, Tokyo Medical University, Tokyo, Japan
Critical Care 2015, 19(Suppl 1):P62 (doi: 10.1186/cc14142)
18.03.2015

Presepsin in Patients with SIRS and Early Sepsis in the Emergency Department

Ricardo Carpio1, Eberhard Spanuth2
1)Hospital Nacional Edgardo Rebagliati Martins-EsSalud, Lima, Peru
2)DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
17.03.2015

Изучение уровня пресепсина у детей и подростков больных туберкулезом органов дыхания

Пискунова О.А, Авербах М.М., Овсянкина Е.С., Панова Л.
Ежемесячный научный медицинский журнал
Интер-медикал № 1(7)/ 2015
03.03.2015

Пресепсин: Биомаркер сепсиса. Краткая монография.

LSI Medience Corporation
13-4 Uchikanda 1-chome, Chiyoda-ku, Tokyo 101 - 8517, Japan
02.03.2015

Determination of reference interval for presepsin, an early marker for sepsis

Davide Giavarina, Mariarosa Carta. Determination of reference interval for presepsin, an early marker for sepsis. Biochemia Medica 2015;25(1):64-8. http://dx.doi.org/10.11613/BM.2015.007 Clinical Chemistry and Haematology Laboratory, San Bortolo Hospital, Vicenza, Italy
02.03.2015

Становление пресепсина как нового биомаркера для диагностики и мониторинга неонатального сепсиса

Ганс-Юрген Кольде, Ральф Томэ
Neonatal Sepsis: The emerging role of Presepsin for diagnosis and monitoring
09.02.2015

Использование биомаркёра «Пресепсин» для ранней и высокоспецифичной диагностики сепсиса

КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ
Ассоциация специалистов и организаций лабораторной службы "ФЕДЕРАЦИЯ ЛАБОРАТОРНОЙ МЕДИЦИНЫ"
09.02.2015

Рекомендации по применению измерений пресепсина

Рекомендации по применению измерений пресепсина утверждённые Федерацией Лабораторной Медицины,
утвержденные в МЗ РФ и опубликованные в ФЭМБ.
05.02.2015

Presepsin (soluble CD14 subtype) in term and preterm newborns

Lorenza Pugni1, Carlo Pietrasanta1, Mariella Falbo1, Tania Todorovic1, Claudia Vener2, Silvano
Milani2, Fabio Mosca1
1NICU, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico, University of Milan, Milan, Italy 2Medical Statistics and
Biometrics Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’
Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Early Human Development, Volume 90, Supplement 2, Pages S64–S65, September 2014
05.02.2015

Пресепсин – новый биомаркер сепсиса: значение для педиатрии

В.В. Вельков
ЗАО «ДИАКОН», г. Пущино Московской области, РФ
1Педиатрия, 2015, том 94, N1, стр. 132-136
05.02.2015

The clinical performance of a point of care assay for measurement of Presepsin in patients with bacteremia

Yasuo Fukui 1) Yoshikazu Okamura 2)
•1) Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi, Japan
•2) Research and Development Division, Yachiyo R&D Department, Mitsubishi Chemical Medience Corporation,Tokyo, Japan
05.02.2015

Serum prepsepsin (soluble cd14-subtype) as a novel useful biomaker for infection in patients with rheumatoid arthritis (ra)

S. Tsuji1, S. Ohshima2, A. Yura3, M. Katayama1, A. Watanabe1, S. Teshigawara1, M. Yoshimura1, E. <br>
Tanaka1, Y. Harada3, Y. Katada3, M. Matsushita1, A. Taura2, A. Kitatoube2, G. Takahashi4, S. Endo4,<br>
J. Hashimoto1, Y. Saeki2.<br>
1 Rheumatology; 2 Clinical Research; 3Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano<br>
Osaka; 4Critical Care Medicine,<br>
Iwate Medical University, Uchimaru, Morioka, Japan
05.02.2015

Presepsin for the diagnosis of late-onset sepsis in preterm newborns

C. Poggi, T.Bianconi, E. Gozzini, M. Genesoro, C. Dani
Careggi University Hospital, Florence, Italy
05.02.2015

Diagnostic and prognostic value of presepsin in preterm deliveries

Abstracts / Journal of Reproductive Immunology 101–102 (2014) 40–60
Karin Malícˇková1,∗, Michal Koucky´ 2, Antonín Parˇízek2,
Kvˇeta Pelinková1, Helena Brodská1, Zdenˇek Hájek2, Anna
Germanová2, Oto Mestek3, Tomáˇs Zima1
1 Institute of Medical Biochemistry and Laboratory Diagnostics,
General University Hospital and 1st Faculty of Medicine
of Charles University in Prague, Czech Republic
2 Department of Gynecology and Obstetrics, General University
Hospital and 1st Faculty of Medicine of Charles University
in Prague, Czech Republic
3 Institute of Chemical Technology Prague, Czech Republic
05.02.2015

Diagnostic and Predictive Value of Presepsin (sCD14-ST) in the Time Course of Sepsis

Michael Behnes¹, Dominic Lepiorz ¹, Siegfried Lang¹, Thorsten Kälsch¹, <br>
Thomas Bertsch², Martina Brueckmann¹*, Martin Borggrefe¹, Ursula Hoffmann¹<br>
First Department of Medicine¹, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Germany<br>
Institute for Clinical Chemistry, Laboratory and Transfusion Medicine², Nuremberg Hospital, Germany
05.02.2015

Assessment of the usefulness of Presepsin (soluble CD14 subtype; sCD14-ST) in septic patients

Takeshi Nishida1, Hiroyasu Ishikura1, Akira Murai1, Yuhei Irie1, Takehiro Umemura1, Takanori Kamitani1, Shigeatsu Endo2, The Presepsin Workshop
1 Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Fukuoka, JAPAN
2 Department of Critical Care Medicine, School of Medicine, Iwate Medical University, Iwate, JAPAN
05.02.2015

Presepsin (soluble CD14 subtype) Is Secreted from Human Monocytes after Phagocytosis

Yasuyuki Arai, MD1, Kouhei Yamashita, MD, PhD1, Kiyomi Mizugishi,
MD, PhD1 and Akifumi Takaori-Kondo, M.D., Ph.D.2
Department of Hematology and Oncology, Kyoto University Graduate
School of Medicine, Kyoto, Japan
Department of Hematology and Oncology, Graduate School of Medicine,
Kyoto University, Kyoto, Japan
05.02.2015

Diagnostic value of presepsin in cirrhotic patients

G. Novelli1, V. Morabito1, G. Ferretti2, N. Gugliemo1, G.B. Levi Sandri1, M. Rossi1, P.B. Berloco1.
1General Surgery and Organs Transplant, 2Tropical and Infectous Disease, Sapienza University, Rome, Italy
Journal of Hepatology Volume 58, Supplement 1 , Pages S95-S96, April 2013
05.02.2015

Diagnostic and prognostic value of serum presepsin in cirrhotic patients with spontaneous bacterial peritonitis

H. Okasha1, A. Elgohary2, A. Abd El Moety2, A. Elbadawy3
Medical microbiology and Immunology, Faculty of medicine Alexandria university, Alexandria, Egypt;
Internal Medicine, Faculty of medicine Alexandria university, Alexandria, Egypt ; Internal Medicine,
Alexandria Police Hospital, Alexandria, Egypt
05.02.2015

Публикации по пресепсину 2005-2014 г.

Список ссылок на публикации по пресепсину за указанные годы.
29.01.2015

Prognostic value of presepsin (soluble cd14 subtype) in critically ill patients with severe sepsis and septic shock

AbdAllah T.H. 1, El-Reweny E.M.1, El-Sawy M.M.2, Aboudeif M.M.1
1Department of Critical Care Medicine, Faculty of Medicine, Alexandria University, Egypt 2Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Egypt
27.01.2015

Presepsin: solving a soluble (CD14) problem in sepsis?

Gareth L. Ackland
John R. Prowle
26.01.2015

Мониторинг уровня SCD14-ST (пресепсина) в периоперационном периоде у кардиохирургических больных

Попов Д.А., Плющ М. Г., Овсеенко С. Т., Абрамян М. В., Подщеколдина О. О.,
Ярустовский М. Б.
ФГБУ НЦ ССХ им. А. Н. Бакулева РАМН
Анестизиология и Реаниматология Номер: 3 Год: 2013 Страницы: 30-35
17.12.2014

Пресепсин — ранний и высокоэффективный маркер сепсиса

В. В. Вельков
ЗАО «ДИАКОН», г. Пущино, Московская область
19.11.2014

Предварительные диагностические уровни пресепсина для принятия клинических решений в ОНТ и ОРИТ

Иошиказу Окамура, Ральф Томэ.
Департамент исследований и разработок
Митсубиси Кемикл Медиенс Корпорэйшн, Япония.
«Лаборатория. Журнал для врачей», 2014, N1, 9-10.
13.10.2014

PreSEPSIN: The Sepsis Biomarker. A short monograph.

LSI Medience Corporation,
Mitsubishi Chemical Europe GmbH.
18.09.2014

PATHFAST Presepsin in Patients with SIRS and Early Sepsis in the Emergency Department

Ricardo Carpio, Eberhard Spanuth
Hospital Nacional Edgardo Rebagliati Martins-EsSalud, Lima, Peru
DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
18.09.2014

Диагностическое и прогностическое значение пресепсина при септическом шоке у онкогематологических больных в состоянии агранулоцитоза. Статья.

Макарова П.М., Галстян Г.М., Кречетова А.В., Гаранжа Т.А.,
Тихомиров Д.С., Паровичникова Е.Н.
ФГБУ «Гематологический научный центр» Минздрава России,
г. Москва
18.09.2014

Материалы XV сессии МНОАР 28 марта 2014 г. С.16-17.

Демидова В.С., Ушакова Т.А., Звягин А.А., Бобровников А.Э., Медова О.В., Коряков
И.А., Казеннов В. В., Шишкин М.Н., Баранова А.А., Самадурова Л.Л., Кучейник А.Ш.
ФГБУ «Институт хирургии им. А.В. Вишневского», Россия, Москва
18.09.2014

Usefulness of presepsin (PSP) for assessment of sepsis in leukopeniс patients (pts)

Makarova P., Galstyan G, Krechetova A, Gemdjian.E, Garandja T, Tichomirov D.,
Parovichnikova E.
National Scientific Center for Hematology, Moscow, Russia
18.09.2014

Роль продленной вено-венозной гемофильтрации в коррекции липополисахаридемии и ассоциированных с ней маркеров грамотрицательного сепсиса

Р.М. Зайцев, А.Ю. Яковлев, А.В. Абрамов, С.Ю. Власкин,
М.Ю. Серопян, А.А. Ниязматов, А.Ю. Сморкалов, Е.Ю. Голубцова
ГБУЗ НО «Нижегородская областная клиническая больница им. Н.А. Семашко»
17.09.2014

Новый маркер сепсиса Пресепсин

Dr. Ralf Thomae
General Manager & Representativ Diagnostic
Business
Mitsubishi Chemical Europe GmbH
17.09.2014

PATHFAST Presepsin Features & Advantages

LSI Medience Corporation
17.09.2014

Presepsin workshop Evaluation Results in Japan

Yoshikazu Okamura
Research and development division
Mitsubishi Chemical Medience Corporation
19/May/2013
17.09.2014

Диагностическое и прогностическое значение пресепсина при септическом шоке у онкогематологических больных в состоянии агранулоцитоза

ФГБУ "Гематологический Научный Центр" Минздрава России. Отделение Реаниматологии и Интенсивной Терапии.
П.М. Макарова, Г.М. Галстян, А.В. Кречетова, Т.А. Гаранжа, Д.С. Тихомиров, Е.Н. Паровичникова
15.09.2014

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

Serge Masson, Pietro Caironi, Eberhard Spanuth, Ralf Thomae, Mauro Panigada, Gabriela Sangiorgi,
Roberto Fumagalli, Tommaso Mauri, Stefano Isgrò, Caterina Fanizza, Marilena Romero, Gianni Tognoni,
Roberto Latini, and Luciano Gattinoni, on behalf of the ALBIOS Study Investigators
Masson et al. Critical Care 2014, 18:R6
15.09.2014

Presepsin as a novel sepsis biomarker

Qi Zou, Wei Wen, Xin-chao Zhang
Emergency Medicine Department, Beijing Hospital, Beijing 100730, China
15.09.2014

A new marker for the diagnosis of sepsis: Presepsin

Mehmet Agilli, Irfan Sener, Fatih Yesildal, Tevfik Honca, Ibrahim Aydin, Emin Ozgur Akgul, Halil Yaman
Department of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey
15.09.2014

New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study

Hiroyasu Ishikura, Takeshi Nishida, Akira Murai, Yoshihiko Nakamura, Yuhei Irie, Junichi Tanaka and Takehiro Umemura
Ishikura et al. Critical Care 2014, 18:R19
15.09.2014

Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department

Bo Liu, Yun-Xia Chen, Qin Yin, Yun-Zhou Zhao and Chun-Sheng Li
Liu et al. Critical Care 2013, 17:R244
15.09.2014

Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study

Marco Ulla, Elisa Pizzolato, Manuela Lucchiari, Maria Loiacono, Flavia Soardo, Daniela Forno,
Fulvio Morello, Enrico Lupia, Corrado Moiraghi, Giulio Mengozzi and Stefania Battista
Ulla et al. Critical Care 2013, 17:R168
11.09.2014

Комплексная лабораторная диагностика системных инфекций и сепсиса: С-реактивный белок, прокальцитонин, пресепсин

В.В. Вельков
11.09.2014

Пресепсин – ранний высокоэффективный биомаркер сепсиса. Краткий обзор

Вельков В.В., ЗАО «ДИАКОН», Пущино, Московская область, 142292.
10.09.2014

Пресепсин – ранний и высокоспецифичный маркер сепсиса: новые возможности

Вельков В.В.
ЗАО «ДИАКОН», г. Пущино, Московская область, 142292.
10.05.2014

Пресепсин: новый биомаркер для прогнозирования и диагностики сепсиса

Иошиказу Окамура, Ральф Томэ
Департамент исследований и разработок Митсубиси Кемикл Медиенс Корпорэйшн, Япония.

Яндекс.Метрика